CA2521117C - Ultrasnoic method and device for wound treatment - Google Patents
Ultrasnoic method and device for wound treatment Download PDFInfo
- Publication number
- CA2521117C CA2521117C CA2521117A CA2521117A CA2521117C CA 2521117 C CA2521117 C CA 2521117C CA 2521117 A CA2521117 A CA 2521117A CA 2521117 A CA2521117 A CA 2521117A CA 2521117 C CA2521117 C CA 2521117C
- Authority
- CA
- Canada
- Prior art keywords
- wound
- ultrasonic energy
- tissue
- achieving
- therapeutic effect
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title abstract description 56
- 206010052428 Wound Diseases 0.000 title description 91
- 208000027418 Wounds and injury Diseases 0.000 title description 87
- 238000011282 treatment Methods 0.000 title description 24
- 239000003814 drug Substances 0.000 claims abstract description 54
- 230000001225 therapeutic effect Effects 0.000 claims abstract description 47
- 230000009286 beneficial effect Effects 0.000 claims abstract description 24
- 230000000149 penetrating effect Effects 0.000 claims abstract description 16
- 230000035876 healing Effects 0.000 claims abstract description 15
- 230000003247 decreasing effect Effects 0.000 claims abstract description 11
- 239000007788 liquid Substances 0.000 claims description 61
- 239000007921 spray Substances 0.000 claims description 60
- 230000005855 radiation Effects 0.000 claims description 52
- 230000008878 coupling Effects 0.000 claims description 16
- 238000010168 coupling process Methods 0.000 claims description 16
- 238000005859 coupling reaction Methods 0.000 claims description 16
- 230000017531 blood circulation Effects 0.000 claims description 4
- 230000010261 cell growth Effects 0.000 claims description 4
- 230000004936 stimulating effect Effects 0.000 claims description 2
- 230000002093 peripheral effect Effects 0.000 claims 4
- 210000001519 tissue Anatomy 0.000 description 99
- 238000002604 ultrasonography Methods 0.000 description 69
- 230000000694 effects Effects 0.000 description 18
- 239000002245 particle Substances 0.000 description 15
- 239000003242 anti bacterial agent Substances 0.000 description 13
- 229940079593 drug Drugs 0.000 description 13
- 241000894006 Bacteria Species 0.000 description 11
- 239000000843 powder Substances 0.000 description 11
- 229940088710 antibiotic agent Drugs 0.000 description 10
- 238000005507 spraying Methods 0.000 description 10
- 239000000443 aerosol Substances 0.000 description 8
- 239000003570 air Substances 0.000 description 8
- 238000013459 approach Methods 0.000 description 7
- 239000003595 mist Substances 0.000 description 7
- 238000009210 therapy by ultrasound Methods 0.000 description 6
- 239000012080 ambient air Substances 0.000 description 5
- 230000000202 analgesic effect Effects 0.000 description 5
- 230000035515 penetration Effects 0.000 description 5
- 238000000554 physical therapy Methods 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 230000003115 biocidal effect Effects 0.000 description 4
- 238000012377 drug delivery Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 3
- -1 e.g. Substances 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 230000000699 topical effect Effects 0.000 description 3
- 239000000730 antalgic agent Substances 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 239000003974 emollient agent Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 239000003589 local anesthetic agent Substances 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 230000036407 pain Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000000527 sonication Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- 230000008733 trauma Effects 0.000 description 2
- 241001553178 Arachis glabrata Species 0.000 description 1
- 208000009043 Chemical Burns Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000003444 anaesthetic effect Effects 0.000 description 1
- 229940035676 analgesics Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000000828 canola oil Substances 0.000 description 1
- 235000019519 canola oil Nutrition 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 230000002301 combined effect Effects 0.000 description 1
- 239000000356 contaminant Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000000249 desinfective effect Effects 0.000 description 1
- 230000001066 destructive effect Effects 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000008241 heterogeneous mixture Substances 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000036640 muscle relaxation Effects 0.000 description 1
- 239000006199 nebulizer Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 230000010349 pulsation Effects 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 238000011477 surgical intervention Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M3/00—Medical syringes, e.g. enemata; Irrigators
- A61M3/02—Enemata; Irrigators
- A61M3/0275—Pulsating jets; Vibrating nozzles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M35/00—Devices for applying media, e.g. remedies, on the human body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N7/00—Ultrasound therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M37/00—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin
- A61M37/0092—Other apparatus for introducing media into the body; Percutany, i.e. introducing medicines into the body by diffusion through the skin using ultrasonic, sonic or infrasonic vibrations, e.g. phonophoresis
Abstract
An apparatus and method are provided for applying a medicament to tissue, and delivering ultrasonic energy from a non-contact distance from the tissue to the medicament and to the tissue, wherein the ultrasonic energy has intensity capable of penetrating the wound tissue to a beneficial depth to provide a therapeutic effect to the tissue, and of sonicating the medicament for causing the medicament to penetrate the tissue to a beneficial depth to provide a therapeutic effect to the tissue. Another apparatus and method are provided for generating ultrasonic energy from a non-contact distance from the surface of the wound; and delivering the generated ultrasonic energy to the wound through a gaseous medium. The generated ultrasonic energy has a significantly large amplitude such that the ultrasonic energy has an intensity capable of penetrating the wound tissue to a beneficial depth to provide a therapeutic effect for decreasing the healing time for the wound.
Description
ULTRASNOIC METHOD AND DEVICE FOR WOUND TREATMENT
Field Of The Invention The present invention relates to methods of using ultrasonic waves in wound treatment. More particularly, the present invention relates to a method of applying a medicament to tissue and delivering ultrasound energy to the medicament and the tissue.
BACKGROUND OF THE INVENTION
Ultrasonic waves have been widely used in medical applications, including for both diagnostics and therapy as well as for many industrial applications. One diagnostic use of ultrasound waves includes using ultrasonic waves to detect underlying structures in an object or a human tissue. In this procedure, an ultrasonic transducer is placed in contact with the object or tissue via a coupling medium, and high frequency (1-10 MHz) ultrasonic waves are directed into the tissue. Upon contact with various underlying structures, the waves are reflected back to a receiver adjacent the transducer. By comparison of the signals of the ultrasonic wave as sent with the reflected ultrasonic wave as received, an image of the underlying structure can be produced. This technique is particularly useful for identifying boundaries between components of tissue and can be used to detect irregular masses, tumors, and the like.
Field Of The Invention The present invention relates to methods of using ultrasonic waves in wound treatment. More particularly, the present invention relates to a method of applying a medicament to tissue and delivering ultrasound energy to the medicament and the tissue.
BACKGROUND OF THE INVENTION
Ultrasonic waves have been widely used in medical applications, including for both diagnostics and therapy as well as for many industrial applications. One diagnostic use of ultrasound waves includes using ultrasonic waves to detect underlying structures in an object or a human tissue. In this procedure, an ultrasonic transducer is placed in contact with the object or tissue via a coupling medium, and high frequency (1-10 MHz) ultrasonic waves are directed into the tissue. Upon contact with various underlying structures, the waves are reflected back to a receiver adjacent the transducer. By comparison of the signals of the ultrasonic wave as sent with the reflected ultrasonic wave as received, an image of the underlying structure can be produced. This technique is particularly useful for identifying boundaries between components of tissue and can be used to detect irregular masses, tumors, and the like.
2 PCT/US2004/010448 Two therapeutic medical uses of ultrasound waves include aerosol mist production and contact physiotherapy. Aerosol mist production makes use of a nebulizer or inhaler to produce an aerosol mist for creating a humid environment and delivering drugs to the lungs. Ultrasonic nebulizers operate by the passage of ultrasound waves of sufficient intensity through a liquid, the waves being directed at an air-liquid interface of the liquid at a point underneath or within the liquid. Liquid particles are ejected from the surface of the liquid into the surrounding air following the disintegration of capillary waves produced by the ultrasound energy. This technique can produce a very fine dense fog or mist. Aerosol mists produced by ultrasound are preferred over aerosol mists produced by other methods because a smaller particle size of aerosol can be obtained with the ultrasonic waves. One of the major shortcoming of inhalers and nebulizers is that the aerosol mist cannot be directed to a target area without an air stream, which decreases the efficiency of the ultrasound energy. Ultrasonic sprayers such as those sold by Sonic and Materials Inc., Misonix Inc., Sono-Tek Inc. (see, for example, U.S. Patents Nos.
4,153,201, 4,655,393, and 5,516,043) operate by passing liquid through a central orifice of an ultrasound instrument-tip.
Major disadvantages of these sprayers include non-uniform particle size, heating of liquid flow, and less efficiency of ultrasound waves because of a demolished end (radiation) surface configuration of the tip.
Contact physiotherapy applies ultrasonic waves directly to tissue in an attempt to produce a physical change in the tissue. In conventional ultrasound physiotherapy, an ultrasonic wave contacts the tissue via a coupling medium. Ultrasonic waves produced by the transducer travel through the coupling medium and into the tissue. The coupling medium is typically a bath of liquid, a jelly applied to the surface to be treated, or a water-filled balloon. Conventional techniques provide ultrasonic waves having an intensity of about 0.1 w/cm2 to
4,153,201, 4,655,393, and 5,516,043) operate by passing liquid through a central orifice of an ultrasound instrument-tip.
Major disadvantages of these sprayers include non-uniform particle size, heating of liquid flow, and less efficiency of ultrasound waves because of a demolished end (radiation) surface configuration of the tip.
Contact physiotherapy applies ultrasonic waves directly to tissue in an attempt to produce a physical change in the tissue. In conventional ultrasound physiotherapy, an ultrasonic wave contacts the tissue via a coupling medium. Ultrasonic waves produced by the transducer travel through the coupling medium and into the tissue. The coupling medium is typically a bath of liquid, a jelly applied to the surface to be treated, or a water-filled balloon. Conventional techniques provide ultrasonic waves having an intensity of about 0.1 w/cm2 to
3 w/cm2 at a frequency of about 0.8 to 3 Megahertz. The treatment is applied to a skin surface for from about 1 to 30 minutes, two or three times a week. The coupling medium can provide a cooling effect which dissipates some of the energy produced by the ultrasonic transducer.
More importantly, a coupling medium or direct contact between the tissue and ultrasonic transducer is necessary to transmit the ultrasonic waves to the skin surface because ambient air is a relatively poor medium for the propagation of ultrasonic waves.
Several beneficial effects have been reported from contact ultrasound physiotherapy, such as, for example, the following: local improvement of the blood circulation, heating of the tissue, accelerated enzyme activity, muscle relaxation, pain reduction, and enhancement of natural healing processes. Despite these beneficial effects, current techniques of medical physiotherapy using ultrasonic waves are limited by the necessity of providing a direct contact interface between the ultrasonic transducer and the tissue to maintain an effective transmission of the ultrasonic waves from the transducer to the tissue.
The necessity of direct contact with or without a coupling medium makes current methods undesirable. Some tissue conditions may be accessible to contact ultrasound devices but would be impractical for contact ultrasound treatment. For example, fresh or open wounds resulting from trauma, bums or surgical interventions are not suitable for direct contact ultrasound treatment because of the structural nature of the open wound and the painful condition associated with those wounds. Moreover, conventional contact ultrasound may have a destructive effect on these types of open wounds due to the close proximity of an oscillating tip of an ultrasonic transducer relative to the already damaged tissue surface.
OBJECT OF THE INVENTION
It is an object of the invention to provide an improved method and device for treating tissue.
It is also an object of this invention to provide a method and device for treating tissue using ultrasonic waves.
It is a further object of the invention to provide a method and device for delivering drugs, killing bacteria, cleansing a surface, or stimulating healthy tissue cell growth.
It is a yet further object of the invention to treat a wound by spraying the surface of the wound with aerosol mist produced by ultrasonic waves.
It is also an object of the invention to provide a method and device for applying a medicament to the tissue before and/or during delivery of ultrasound energy to the tissue.
These and other objects of the invention will become more apparent from the discussion below.
SUMMARY OF THE INVENTION
The present invention provides an apparatus and a method for treating tissue, the apparatus including a generator and a transducer for generating ultrasonic energy and delivering the ultrasonic energy to the biological tissue, from a non-contact distance from the tissue, wherein the generated ultrasonic energy has an intensity capable of penetrating the wound tissue to a beneficial depth to provide a therapeutic effect to the tissue, and of sonicating the medicament for causing the medicament to penetrate the tissue to a beneficial depth to provide a therapeutic effect to the tissue.
The present invention further provides an apparatus and method for generating ultrasonic energy from a non-contact distance from the surface of the wound; and delivering the generated ultrasonic energy to the wound through a gaseous medium ("dry" approach), wherein the generated ultrasonic energy has an intensity capable of penetrating the wound tissue to a beneficial depth to provide a therapeutic effect for decreasing the healing time for the wound.
The present invention further relates to a method and device for spraying ("wet" approach) a wound surface to deliver drugs, kill bacteria, or cleanse a surface by non-contact application of an ultrasound transducer tip. The method applies ultrasonic waves to the wound without requiring direct or indirect (via a traditional coupling medium) contact between the ultrasonic wave transducer and the wound to be sprayed.
The method of the invention comprises producing a directed spray of liquid or powder particles produced by contact of the liquid or powder with a free end surface of an ultrasonic transducer. The ultrasonic waves cause the spray to project outwardly from the distal end surface of the ultrasonic transducer, and the particle spray is directed onto the wound. The particles of the spray provide a medium for propagation of the ultrasonic waves emanating from the distal end surface. According to the method of the present invention a directed particle spray created by low frequency ultrasound waves onto a wound, delivers drug, kills bacteria on the wound, increases blood flow, and removes dirt and other contaminants from the wound's surface (mechanical cleansing).
More importantly, a coupling medium or direct contact between the tissue and ultrasonic transducer is necessary to transmit the ultrasonic waves to the skin surface because ambient air is a relatively poor medium for the propagation of ultrasonic waves.
Several beneficial effects have been reported from contact ultrasound physiotherapy, such as, for example, the following: local improvement of the blood circulation, heating of the tissue, accelerated enzyme activity, muscle relaxation, pain reduction, and enhancement of natural healing processes. Despite these beneficial effects, current techniques of medical physiotherapy using ultrasonic waves are limited by the necessity of providing a direct contact interface between the ultrasonic transducer and the tissue to maintain an effective transmission of the ultrasonic waves from the transducer to the tissue.
The necessity of direct contact with or without a coupling medium makes current methods undesirable. Some tissue conditions may be accessible to contact ultrasound devices but would be impractical for contact ultrasound treatment. For example, fresh or open wounds resulting from trauma, bums or surgical interventions are not suitable for direct contact ultrasound treatment because of the structural nature of the open wound and the painful condition associated with those wounds. Moreover, conventional contact ultrasound may have a destructive effect on these types of open wounds due to the close proximity of an oscillating tip of an ultrasonic transducer relative to the already damaged tissue surface.
OBJECT OF THE INVENTION
It is an object of the invention to provide an improved method and device for treating tissue.
It is also an object of this invention to provide a method and device for treating tissue using ultrasonic waves.
It is a further object of the invention to provide a method and device for delivering drugs, killing bacteria, cleansing a surface, or stimulating healthy tissue cell growth.
It is a yet further object of the invention to treat a wound by spraying the surface of the wound with aerosol mist produced by ultrasonic waves.
It is also an object of the invention to provide a method and device for applying a medicament to the tissue before and/or during delivery of ultrasound energy to the tissue.
These and other objects of the invention will become more apparent from the discussion below.
SUMMARY OF THE INVENTION
The present invention provides an apparatus and a method for treating tissue, the apparatus including a generator and a transducer for generating ultrasonic energy and delivering the ultrasonic energy to the biological tissue, from a non-contact distance from the tissue, wherein the generated ultrasonic energy has an intensity capable of penetrating the wound tissue to a beneficial depth to provide a therapeutic effect to the tissue, and of sonicating the medicament for causing the medicament to penetrate the tissue to a beneficial depth to provide a therapeutic effect to the tissue.
The present invention further provides an apparatus and method for generating ultrasonic energy from a non-contact distance from the surface of the wound; and delivering the generated ultrasonic energy to the wound through a gaseous medium ("dry" approach), wherein the generated ultrasonic energy has an intensity capable of penetrating the wound tissue to a beneficial depth to provide a therapeutic effect for decreasing the healing time for the wound.
The present invention further relates to a method and device for spraying ("wet" approach) a wound surface to deliver drugs, kill bacteria, or cleanse a surface by non-contact application of an ultrasound transducer tip. The method applies ultrasonic waves to the wound without requiring direct or indirect (via a traditional coupling medium) contact between the ultrasonic wave transducer and the wound to be sprayed.
The method of the invention comprises producing a directed spray of liquid or powder particles produced by contact of the liquid or powder with a free end surface of an ultrasonic transducer. The ultrasonic waves cause the spray to project outwardly from the distal end surface of the ultrasonic transducer, and the particle spray is directed onto the wound. The particles of the spray provide a medium for propagation of the ultrasonic waves emanating from the distal end surface. According to the method of the present invention a directed particle spray created by low frequency ultrasound waves onto a wound, delivers drug, kills bacteria on the wound, increases blood flow, and removes dirt and other contaminants from the wound's surface (mechanical cleansing).
-4-This method of drug delivery is particularly advantageous on tissues for which local topical application of a drug is desirable but contact with the tissue is to be avoided.
Furthermore, the low frequency ultrasound waves used in the method energize the drug and cause penetration of the drug below the surface of the tissue, due to acoustic pressure, microcavitation, etc. Finally, the bacteria killing method is effective when applied to the surface whether the liquid or powder sprayed is a drug (an antiseptic or antibiotic), oil, saline, distilled water, etc.
In a broad aspect, the present invention relates to an apparatus for treating a wound comprising: means for generating ultrasonic energy; and means for delivering the generated ultrasonic energy to the wound through a gaseous medium from a non-contact distance from the surface of the wound in the absence of a coupling medium and without direct contact between the apparatus and the wound, wherein the generated ultrasonic energy has an intensity capable of penetrating the wound to a beneficial depth to provide a therapeutic effect for decreasing the healing time for the wound, and wherein the non-contact distance is at least 2.5mm from the surface of the wound.
In another broad aspect, the present invention relates to an apparatus for treating a wound comprising: means for generating ultrasonic energy having a an amplitude of at least 3 microns; and means for delivering the generated ultrasonic energy to the wound through a gaseous medium from a non-contact distance from the surface of the wound and without direct contact between an apparatus for generating and delivering ultrasonic energy and the wound or patient tissue, wherein the gaseous medium does not include a liquid spray or other coupling medium, wherein the generated ultrasonic energy has an intensity capable of penetrating the wound tissue to a beneficial depth to provide a therapeutic effect for decreasing the healing time for the wound, wherein the particular amplitude is indicative of an intensity capable of achieving the therapeutic effect, and wherein the non-contact distance is at least 2.5mm from the surface of the wound.
In another broad aspect, the present invention relates to an apparatus for treating a wound comprising: means for generating ultrasonic energy having a frequency in the range of 20-200kHz and having an amplitude of at least 3 microns; and means for delivering the generated ultrasonic energy to the wound through a gaseous medium from a non-contact distance from the surface of the wound and without direct contact between an apparatus for generating and delivering ultrasonic energy and the wound or patient tissue, wherein the gaseous medium does not include a liquid spray or other coupling medium, wherein the generated ultrasonic energy has an intensity capable of penetrating the wound tissue to a beneficial depth to provide a therapeutic effect for decreasing the healing time for the wound, wherein the frequency is capable of achieving a particular amplitude indicative of an intensity capable of achieving the therapeutic effect, and wherein the non-contact distance is at least 2.5mm from the surface of the wound.
In another broad aspect, the present invention relates to an apparatus for treating a wound comprising: means for generating ultrasonic energy having an amplitude of at least 10 microns; and means for delivering the generated ultrasonic energy to the wound through a gaseous medium from a non-contact distance from the surface of the wound and without direct contact between an apparatus for generating and delivering ultrasonic energy and the wound or patient tissue, wherein the gaseous medium does not include a liquid spray or other coupling medium, wherein the generated ultrasonic energy has an intensity capable of penetrating the wound tissue to a beneficial depth to provide a therapeutic effect for decreasing the healing time for the wound, and wherein the non-contact distance is at least 2.5mm from the surface of the wound.
In another broad aspect, the present invention relates to an apparatus for treating tissue comprising: a generator and a transducer for generating ultrasonic energy with an amplitude of at least 3 microns; wherein the transducer delivers the ultrasonic energy to the tissue and to a medicament separately applied to the tissue from a non-contact distance from the tissue and the medicament; and wherein the generated ultrasonic energy has an intensity capable of applying acoustic pressure and penetrating the wound tissue to a beneficial depth to provide a therapeutic effect to the tissue, and of sonicating the medicament for causing the medicament to penetrate the tissue to a beneficial depth to provide a therapeutic effect to the tissue.
BRIEF DESCRIPTION OF THE DRAWINGS
Fig. 1 is a perspective view of an ultrasonic wound treatment system according to the present invention;
5a Fig. 2 is a lateral schematic view of an ultrasonic sprayer according to the present invention;
Fig. 3 is a partly cross-sectional view of an ultrasonic sprayer according to the present invention;
Fig. 4a is a detailed view of the sprayer illustrated in Fig. 3 for spraying liquid from a radiation surface;
Fig. 4b is a detailed view of the sprayer illustrated in Fig. 3 for spraying liquid from a side (radial) surface;
Fig. 5 is a cross-sectional front view of a distal end of an ultrasonic transducer when liquid is delivered to the side or radiation surface of the transducer tip from 360 along its perimeter;
Fig. 6 is a variation of Fig. 4b illustrating the spraying effect by changing the angle between the ultrasound instrument and horizontal line from 0 to 90 ;
Figs. 7a-7g are each a front cross-sectional view of an ultrasound tip configuration;
Figs. 8a-8i are each an enlarged side view of a different modification of a tip end shape of the ultrasonic sprayer according to the present invention;
Figs. 9a, 9b, and 9c represent cross-sectional, distal, and lateral views, respectively, of the top of an ultrasonic sprayer having a slot, groove, or thread;
Fig. 10 is a schematic representation of a method of delivery of ultrasonic energy delivered through a gaseous medium, accordance with another embodiment of the present invention ; and Fig. 11 is a plot of experimental results achieved upon delivering ultrasound energy substantially through a gaseous medium to a wound in accordance with the present invention.
5b DETAILED DESCRIPTION OF THE INVENTION
The device of the invention that produces a spray is characterized by means for first delivering the liquid to a lateral surface of an ultrasonic transducer tip adjacent to a free end surface such that the liquid is pulled to the free end surface by a vacuum (negative pressure) created by the ultrasound waves on the free end surface of the transducer tip. This effect can be achieved while the angle between the ultrasound instrument and the horizontal is modified up to 90 . (This acoustical effect of delivering liquid from radial side of a tip to the free end was discovered by the inventor of this invention and is called the "Babaev effect".) This effect occurs when liquid is delivered to the radial surface of a transducer tip about its perimeter, up to 360 about its perimeter, e.g. from the top, side, bottom, etc.
For the above purpose the device preferably has a so-called nozzle constructed from steel (non-disposable) or plastic (disposable) with a suitable valve design. The nozzle allows delivery of liquid to the lateral surface of the transducer tip or directly to the distal side (radiation surface) of the ultrasound transducer, for enabling the transducer to act as a sprayer or atomizer.
One of the major advantages of the invention is the uniformity of the spray particles generated. Because liquid or powder is sprayed from a solid radiation surface, there is substantial uniformity of particle size, about 90% or greater, preferably from about 90 to 96%. It is provided that the distal radiation surface is driven with constant frequency and amplitude to create the spray. It is also provided that the frequency and/or amplitude can be modulated during treatment and that the distal radiation surface is driven with a sinusoidal, rectangular, trapezoidal or triangular wave form.
The step of producing the spray can further include operating the transducer to produce ultrasonic waves having a frequency of from about 18kHz to 10,000 MHz.
Frequencies below 18 kHz, i.e., from about 1 to 18 kHz, can be used as well; however, this lower range is less desirable because this range of sound wave can be uncomfortable to the patient and operator (without ear protection or the like). Frequencies in the range of from about 30 to 100 kHz are preferred, and frequencies of about 40 kHz are most preferred.
The separation distance between the free end surface of the transducer and the surface or object to be sprayed should be a "non-contact" distance of at least 0.1 in.
(2.5 mm). Preferably the separation distance is from about 0.1 in. (2.5 mm) to 20 in. (51 can), more preferably from about 0.1 in. (2.5 mm) to 5 in. (12.7 cm). The liquid or powder to be sprayed can be any appropriate carrier such as water (regular or distilled), saline solution, or oil to be applied to tissue (i.e., biological tissue or non-biological tissue), such as a vegetable, peanut, or canola oil, optionally with a soluble pharmaceutical, e.g., an antibiotic, antiseptic, conditioner, surfactant, emollient, or other active ingredient. The pharmaceutical or the like is preferably present in a concentration sufficiently low to be soluble but high enough to be effective for the intended purpose.
It is within the scope of the invention that the liquid to be sprayed could include a mixture of two or more immiscible liquids or a heterogeneous mixture of a solution and small particles. It is also within the scope of the invention that the spray could include particles, such as powder, and that the liquid in the reservoir could include powder.
The spray produced according to the invention is directed to the object, surface, or tissue to be sprayed for the time and frequency required for accomplishing a particular purpose or treatment.
It is believed that a minimum length of spray of at least one second will be required; however, the length or duration of the spray could be from about one second to as much as a minute or more, even 30 minutes. Numerous factors or circumstances, such as, for example, the area to be sprayed (e.g., the size of a wound), the volume rate of spray produced, the concentration of active ingredient, etc., will impact upon the duration and/or frequency of the spraying. Spraying could be required from one or more times daily to as little as two or three times a week or month.
According to the invention, ultrasonic waves are applied to a wound without establishing contact, directly or indirectly, between the ultrasonic transducer and the wound. For example, surfaces of the human body especially suited for treatment in accordance with the method of the present invention include infected and inflammatory situations in open wounds, including trauma or gun shut wounds, fire and chemical burns.
In addition, the method of the present invention is particularly suited to directing a spray into orifices or other body crevices that are difficult to access.
Wound treatment according to the method and apparatus of the present invention has several advantages. First, this method topically applies medicines such as liquid antibiotics to the wound surface without the need to contact infected, inflamed or painful tissue with an instrument.
And second, a significant bactericidal effect occurs when a wound surface is sprayed using the method of the present invention.
Moreover, aside from the bactericidal effect and advantages of non-contact treatment, it has been found that using the method of the present invention gave a significant reduction in volume used of liquid medicine used as compared with traditional methods for wound treatment. Similarly, this allows for precise dosage of the sprayed liquid to permit a user, such as a physician, to administer the desired volume of liquid at a desired rate and duration.
It has been found that the method of the present invention decreases healing times for inflammatory and purulent infected wounds from about 1.5 to 3 times faster than traditional methods. This effect results from a bactericidal, blood flow increasing and mechanical cleansing effect of the atomized spray particles, which have ultrasound energy due to the ultrasonic waves.
The spray mechanically scrubs the surface of tissue to remove dirt, dead tissue, and purulent buildup on the tissue surface. The mentioned healing effect also results of energized and highly activated antibiotics, and drug penetration into the tissue surface up to 0.5 mm in depth under influence of ultrasound waves.
Additionally, a combination of the low frequency ultrasonic waves and the sonicated medicines (highly activated by ultrasonic energy) destroys the surface bacteria, resulting in a higher disinfecting property of sonicated liquids as compared to ordinarily applied liquids.
The spray of the present method also stimulates healthy cell growth to aid in granulation and epithelization of the healing tissue.
-g-Other applications of the invention can be directed to non-medical uses such as cleansing, sterilizing and coating surfaces of objects and food.
The method of the present invention offers an approach that may re-establish use of some traditional antibiotics and establish a method for fighting bacteria without antibiotics when necessary. The effect of the method of the present invention in highly activating antibiotics may allow some traditional antibiotics to overcome bacteria which have become resistant to that antibiotic. Moreover, independent of the sonication effect of the antibiotics, the low frequency ultrasonic waves applied in accordance with the method of the present invention physically destroy bacteria. The combination of the highly activated antibiotics and of the low frequency ultrasonic waves in accordance with the method of the present invention produce a strong bactericidal effect not found in mere topical application or oral ingestion of antibiotics. This combined effect has been shown to significantly increase the healing of purulent infected wounds.
The present method also provides a system of non-contact drug delivery without use of a compression sprayer system. This simplifies the design of a non-contact drug delivery sprayer and reduces the weight of the sprayer. More importantly, not using compression to propel the atomized particles preserves the ultrasound energy carried by the spray particles.
Delivery of ultrasound energy in accordance with the present invention has been proven to destroy bacteria by action of the ultrasonic waves and by highly activated liquid medicines applied to the tissue.
The method of the present invention provides a method of compressionless non-contact drug delivery.
The invention is better appreciated by making reference to the drawings. In Fig. 1, an ultrasonic treatment system 2 includes an ultrasound generator 4, connected to an ultrasound transducer 6 by a cable 8. The generator 4, which is conventional, may have a front panel 10 with a power button 12, a timer 14, a control button 16, a display 18, and one or more jacks 20, for example, for connecting a footswitch. A nozzle 22 having a liquid reservoir 24 with a valve 26 is attached to the distal portion of transducer 6. Arrows 28 represent the direction of the spray produced.
Fig. 2 is a simplified representation of an ultrasonic device and spray according to the invention. Transducer 6 has a distal transducer tip or horn 30. Liquid from a liquid reservoir 32 flows through a valve 34 to a position adjacent the distal radiation surface 36 of a horn 30.
Transducer 6 is attached to an ultrasound source via cable 8. A liquid mist is directed in the direction of arrows 38 to target tissue or surface 40 (wet approach).
Fig. 3 is an enlarged, partly cross-sectional view of a section of Fig. 1 illustrating a spray created by the device according to the method of the present invention. This device is a modification and implementation of a device disclosed in U.S. Patent No.
Furthermore, the low frequency ultrasound waves used in the method energize the drug and cause penetration of the drug below the surface of the tissue, due to acoustic pressure, microcavitation, etc. Finally, the bacteria killing method is effective when applied to the surface whether the liquid or powder sprayed is a drug (an antiseptic or antibiotic), oil, saline, distilled water, etc.
In a broad aspect, the present invention relates to an apparatus for treating a wound comprising: means for generating ultrasonic energy; and means for delivering the generated ultrasonic energy to the wound through a gaseous medium from a non-contact distance from the surface of the wound in the absence of a coupling medium and without direct contact between the apparatus and the wound, wherein the generated ultrasonic energy has an intensity capable of penetrating the wound to a beneficial depth to provide a therapeutic effect for decreasing the healing time for the wound, and wherein the non-contact distance is at least 2.5mm from the surface of the wound.
In another broad aspect, the present invention relates to an apparatus for treating a wound comprising: means for generating ultrasonic energy having a an amplitude of at least 3 microns; and means for delivering the generated ultrasonic energy to the wound through a gaseous medium from a non-contact distance from the surface of the wound and without direct contact between an apparatus for generating and delivering ultrasonic energy and the wound or patient tissue, wherein the gaseous medium does not include a liquid spray or other coupling medium, wherein the generated ultrasonic energy has an intensity capable of penetrating the wound tissue to a beneficial depth to provide a therapeutic effect for decreasing the healing time for the wound, wherein the particular amplitude is indicative of an intensity capable of achieving the therapeutic effect, and wherein the non-contact distance is at least 2.5mm from the surface of the wound.
In another broad aspect, the present invention relates to an apparatus for treating a wound comprising: means for generating ultrasonic energy having a frequency in the range of 20-200kHz and having an amplitude of at least 3 microns; and means for delivering the generated ultrasonic energy to the wound through a gaseous medium from a non-contact distance from the surface of the wound and without direct contact between an apparatus for generating and delivering ultrasonic energy and the wound or patient tissue, wherein the gaseous medium does not include a liquid spray or other coupling medium, wherein the generated ultrasonic energy has an intensity capable of penetrating the wound tissue to a beneficial depth to provide a therapeutic effect for decreasing the healing time for the wound, wherein the frequency is capable of achieving a particular amplitude indicative of an intensity capable of achieving the therapeutic effect, and wherein the non-contact distance is at least 2.5mm from the surface of the wound.
In another broad aspect, the present invention relates to an apparatus for treating a wound comprising: means for generating ultrasonic energy having an amplitude of at least 10 microns; and means for delivering the generated ultrasonic energy to the wound through a gaseous medium from a non-contact distance from the surface of the wound and without direct contact between an apparatus for generating and delivering ultrasonic energy and the wound or patient tissue, wherein the gaseous medium does not include a liquid spray or other coupling medium, wherein the generated ultrasonic energy has an intensity capable of penetrating the wound tissue to a beneficial depth to provide a therapeutic effect for decreasing the healing time for the wound, and wherein the non-contact distance is at least 2.5mm from the surface of the wound.
In another broad aspect, the present invention relates to an apparatus for treating tissue comprising: a generator and a transducer for generating ultrasonic energy with an amplitude of at least 3 microns; wherein the transducer delivers the ultrasonic energy to the tissue and to a medicament separately applied to the tissue from a non-contact distance from the tissue and the medicament; and wherein the generated ultrasonic energy has an intensity capable of applying acoustic pressure and penetrating the wound tissue to a beneficial depth to provide a therapeutic effect to the tissue, and of sonicating the medicament for causing the medicament to penetrate the tissue to a beneficial depth to provide a therapeutic effect to the tissue.
BRIEF DESCRIPTION OF THE DRAWINGS
Fig. 1 is a perspective view of an ultrasonic wound treatment system according to the present invention;
5a Fig. 2 is a lateral schematic view of an ultrasonic sprayer according to the present invention;
Fig. 3 is a partly cross-sectional view of an ultrasonic sprayer according to the present invention;
Fig. 4a is a detailed view of the sprayer illustrated in Fig. 3 for spraying liquid from a radiation surface;
Fig. 4b is a detailed view of the sprayer illustrated in Fig. 3 for spraying liquid from a side (radial) surface;
Fig. 5 is a cross-sectional front view of a distal end of an ultrasonic transducer when liquid is delivered to the side or radiation surface of the transducer tip from 360 along its perimeter;
Fig. 6 is a variation of Fig. 4b illustrating the spraying effect by changing the angle between the ultrasound instrument and horizontal line from 0 to 90 ;
Figs. 7a-7g are each a front cross-sectional view of an ultrasound tip configuration;
Figs. 8a-8i are each an enlarged side view of a different modification of a tip end shape of the ultrasonic sprayer according to the present invention;
Figs. 9a, 9b, and 9c represent cross-sectional, distal, and lateral views, respectively, of the top of an ultrasonic sprayer having a slot, groove, or thread;
Fig. 10 is a schematic representation of a method of delivery of ultrasonic energy delivered through a gaseous medium, accordance with another embodiment of the present invention ; and Fig. 11 is a plot of experimental results achieved upon delivering ultrasound energy substantially through a gaseous medium to a wound in accordance with the present invention.
5b DETAILED DESCRIPTION OF THE INVENTION
The device of the invention that produces a spray is characterized by means for first delivering the liquid to a lateral surface of an ultrasonic transducer tip adjacent to a free end surface such that the liquid is pulled to the free end surface by a vacuum (negative pressure) created by the ultrasound waves on the free end surface of the transducer tip. This effect can be achieved while the angle between the ultrasound instrument and the horizontal is modified up to 90 . (This acoustical effect of delivering liquid from radial side of a tip to the free end was discovered by the inventor of this invention and is called the "Babaev effect".) This effect occurs when liquid is delivered to the radial surface of a transducer tip about its perimeter, up to 360 about its perimeter, e.g. from the top, side, bottom, etc.
For the above purpose the device preferably has a so-called nozzle constructed from steel (non-disposable) or plastic (disposable) with a suitable valve design. The nozzle allows delivery of liquid to the lateral surface of the transducer tip or directly to the distal side (radiation surface) of the ultrasound transducer, for enabling the transducer to act as a sprayer or atomizer.
One of the major advantages of the invention is the uniformity of the spray particles generated. Because liquid or powder is sprayed from a solid radiation surface, there is substantial uniformity of particle size, about 90% or greater, preferably from about 90 to 96%. It is provided that the distal radiation surface is driven with constant frequency and amplitude to create the spray. It is also provided that the frequency and/or amplitude can be modulated during treatment and that the distal radiation surface is driven with a sinusoidal, rectangular, trapezoidal or triangular wave form.
The step of producing the spray can further include operating the transducer to produce ultrasonic waves having a frequency of from about 18kHz to 10,000 MHz.
Frequencies below 18 kHz, i.e., from about 1 to 18 kHz, can be used as well; however, this lower range is less desirable because this range of sound wave can be uncomfortable to the patient and operator (without ear protection or the like). Frequencies in the range of from about 30 to 100 kHz are preferred, and frequencies of about 40 kHz are most preferred.
The separation distance between the free end surface of the transducer and the surface or object to be sprayed should be a "non-contact" distance of at least 0.1 in.
(2.5 mm). Preferably the separation distance is from about 0.1 in. (2.5 mm) to 20 in. (51 can), more preferably from about 0.1 in. (2.5 mm) to 5 in. (12.7 cm). The liquid or powder to be sprayed can be any appropriate carrier such as water (regular or distilled), saline solution, or oil to be applied to tissue (i.e., biological tissue or non-biological tissue), such as a vegetable, peanut, or canola oil, optionally with a soluble pharmaceutical, e.g., an antibiotic, antiseptic, conditioner, surfactant, emollient, or other active ingredient. The pharmaceutical or the like is preferably present in a concentration sufficiently low to be soluble but high enough to be effective for the intended purpose.
It is within the scope of the invention that the liquid to be sprayed could include a mixture of two or more immiscible liquids or a heterogeneous mixture of a solution and small particles. It is also within the scope of the invention that the spray could include particles, such as powder, and that the liquid in the reservoir could include powder.
The spray produced according to the invention is directed to the object, surface, or tissue to be sprayed for the time and frequency required for accomplishing a particular purpose or treatment.
It is believed that a minimum length of spray of at least one second will be required; however, the length or duration of the spray could be from about one second to as much as a minute or more, even 30 minutes. Numerous factors or circumstances, such as, for example, the area to be sprayed (e.g., the size of a wound), the volume rate of spray produced, the concentration of active ingredient, etc., will impact upon the duration and/or frequency of the spraying. Spraying could be required from one or more times daily to as little as two or three times a week or month.
According to the invention, ultrasonic waves are applied to a wound without establishing contact, directly or indirectly, between the ultrasonic transducer and the wound. For example, surfaces of the human body especially suited for treatment in accordance with the method of the present invention include infected and inflammatory situations in open wounds, including trauma or gun shut wounds, fire and chemical burns.
In addition, the method of the present invention is particularly suited to directing a spray into orifices or other body crevices that are difficult to access.
Wound treatment according to the method and apparatus of the present invention has several advantages. First, this method topically applies medicines such as liquid antibiotics to the wound surface without the need to contact infected, inflamed or painful tissue with an instrument.
And second, a significant bactericidal effect occurs when a wound surface is sprayed using the method of the present invention.
Moreover, aside from the bactericidal effect and advantages of non-contact treatment, it has been found that using the method of the present invention gave a significant reduction in volume used of liquid medicine used as compared with traditional methods for wound treatment. Similarly, this allows for precise dosage of the sprayed liquid to permit a user, such as a physician, to administer the desired volume of liquid at a desired rate and duration.
It has been found that the method of the present invention decreases healing times for inflammatory and purulent infected wounds from about 1.5 to 3 times faster than traditional methods. This effect results from a bactericidal, blood flow increasing and mechanical cleansing effect of the atomized spray particles, which have ultrasound energy due to the ultrasonic waves.
The spray mechanically scrubs the surface of tissue to remove dirt, dead tissue, and purulent buildup on the tissue surface. The mentioned healing effect also results of energized and highly activated antibiotics, and drug penetration into the tissue surface up to 0.5 mm in depth under influence of ultrasound waves.
Additionally, a combination of the low frequency ultrasonic waves and the sonicated medicines (highly activated by ultrasonic energy) destroys the surface bacteria, resulting in a higher disinfecting property of sonicated liquids as compared to ordinarily applied liquids.
The spray of the present method also stimulates healthy cell growth to aid in granulation and epithelization of the healing tissue.
-g-Other applications of the invention can be directed to non-medical uses such as cleansing, sterilizing and coating surfaces of objects and food.
The method of the present invention offers an approach that may re-establish use of some traditional antibiotics and establish a method for fighting bacteria without antibiotics when necessary. The effect of the method of the present invention in highly activating antibiotics may allow some traditional antibiotics to overcome bacteria which have become resistant to that antibiotic. Moreover, independent of the sonication effect of the antibiotics, the low frequency ultrasonic waves applied in accordance with the method of the present invention physically destroy bacteria. The combination of the highly activated antibiotics and of the low frequency ultrasonic waves in accordance with the method of the present invention produce a strong bactericidal effect not found in mere topical application or oral ingestion of antibiotics. This combined effect has been shown to significantly increase the healing of purulent infected wounds.
The present method also provides a system of non-contact drug delivery without use of a compression sprayer system. This simplifies the design of a non-contact drug delivery sprayer and reduces the weight of the sprayer. More importantly, not using compression to propel the atomized particles preserves the ultrasound energy carried by the spray particles.
Delivery of ultrasound energy in accordance with the present invention has been proven to destroy bacteria by action of the ultrasonic waves and by highly activated liquid medicines applied to the tissue.
The method of the present invention provides a method of compressionless non-contact drug delivery.
The invention is better appreciated by making reference to the drawings. In Fig. 1, an ultrasonic treatment system 2 includes an ultrasound generator 4, connected to an ultrasound transducer 6 by a cable 8. The generator 4, which is conventional, may have a front panel 10 with a power button 12, a timer 14, a control button 16, a display 18, and one or more jacks 20, for example, for connecting a footswitch. A nozzle 22 having a liquid reservoir 24 with a valve 26 is attached to the distal portion of transducer 6. Arrows 28 represent the direction of the spray produced.
Fig. 2 is a simplified representation of an ultrasonic device and spray according to the invention. Transducer 6 has a distal transducer tip or horn 30. Liquid from a liquid reservoir 32 flows through a valve 34 to a position adjacent the distal radiation surface 36 of a horn 30.
Transducer 6 is attached to an ultrasound source via cable 8. A liquid mist is directed in the direction of arrows 38 to target tissue or surface 40 (wet approach).
Fig. 3 is an enlarged, partly cross-sectional view of a section of Fig. 1 illustrating a spray created by the device according to the method of the present invention. This device is a modification and implementation of a device disclosed in U.S. Patent No.
5,076,266, which is incorporated herein by reference. As can be seen in more detail in Fig. 3, nozzle 22 surrounds ultrasound horn 30. Also, liquid reservoir 32 has a valve 34 positioned between reservoir 32 and the distal surface 36 of ultrasonic horn 30. A conical spray pattern of liquid particles 42 is directed at a surface or tissue 44 of a target. This configuration is effective to spray liquid onto a surface and to deliver ultrasonic waves to that surface, such as, for example, the surface of a wound.
Valve 34 allows liquid to flow to distal tip 36 as drops or as a continuous flow through gap 46. Valve 34 may be located anywhere, including between reservoir 32 and horn 30.
Mechanical movement of the horn 30 in the direction x-x causes liquid to flow to the distal end of radiation surface 36.
Fig. 4(a) is a view of the ultrasonic sprayer as used in accordance with the method of the present invention for spraying liquid 48 directed to distal end (radiation surface) 36.
Fig. 4(b) is a view of the basic spraying method from side (radial) surface of the tip based on the Babaev effect. In this example, liquid or drug directed to the radiation surface 36 of ultrasound horn 30 becomes sonicated (ultrasonically energized), after being pulled forward by negative pressure (vacuum) created by ultrasound waves and sprays.
As shown in Fig. 5, liquid is delivered to the side of radiation surface 36 of transducer horn 30 about the perimeter of radiation surface 36, up to 360 about its perimeter, e.g. from the top, side, bottom, etc.
In the embodiment of the invention shown in Fig. 6, a partial section of transducer horn 30 is elevated from the horizontal up to 90 . Due to the Babaev effect, liquid 48 still travels to radiation surface 36.
The ultrasound tip or horn may have a regular or irregular lateral cross-section, including circular, oval, elliptical, rectangular, trapezoidal, or a combination thereof. For example, Figs. 7(a) to 7(g) are each a view of a cross-section of an ultrasound tip or horn.
Also, the distal end shape of the ultrasound tip or horn longitudinal cross-section may vary, and may be rectangular, elliptical, oval, spherical, conical, curved, stepped, with chamfer, etc., as shown in Figs. 8(a) to 8(n), which are each an enlarged view in section of a different, exemplary modification of a tip of the sprayer as used in accordance with the method of the present invention. The preferred shape is rectangular, because radiation beams from ultrasound tip surface are substantially fully directed to the target (wound). With the spherical, elliptic and oval (Fig. 8(e)) form or shape of the distal end, radiation beams are focused at a focal point.
However, with other forms or shapes of the distal end, radiation beams are spread, thus partially reaching the target.
Radial side surface of the distal end of the tip may have a slot (groove) or thread for liquid to be directed to the radiation surface (Figs. 9a-9c).
Figs. 9a to 9c are each a view of a radial side surface of the distal end of the tip which has a slot (groove) 19 or thread 20 for liquid to be directed to the radiation surface.
The ultrasonic energy delivered has an intensity capable of providing a therapeutic effect to the wound 40, exerting acoustic pressure and/or causing micro-cavitation.
Acoustic pressure refers to a force that can be felt which is exerted through air between the transducer and the tissue being targeted. Microcavitation refers to the formation and pulsation of gas or vapor filled microscopic bubbles in fluids as a result of ultrasonically induced and regularly repeated pressure changes. Advantages to microcavitation include the creation of acoustic streaming which is a steady circulation of fluid in blood vessels induced by ultrasound radiation force.
Preferably, the amplitude achieved by the ultrasonic energy is at least 3 microns and preferably at least 10 microns. Preferably, the frequency used is in the range of 20kHz-50MHz, wherein a preferred range is 20-200kHz, a more preferred range is 20-40kHz and a most preferred value is 40kHz, wherein most preferably the lower limit of the frequency used is outside of the human hearing range.
Furthermore, it is advantageous to use a radiation surface 36 having a shape and size selected to achieve delivery of the ultrasonic energy to the wound where the delivered ultrasonic energy has an intensity capable of providing a therapeutic effect to the wound. Selection of the shape and size of the radiation surface 36 in combination with selection of the frequency and amplitude of the ultrasonic energy used is advantageous in achieving delivery of the ultrasonic energy to the wound wherein the ultrasonic energy has an intensity capable of achieving a therapeutic effect to the wound. Preferably, the radiation surface 36 has a relatively large diameter. Actual selection of the diameter is dependent upon the frequency and amplitude selected. Furthermore, the shape of the radiation surface 36 is selected from one of flat, concave, convex, or a combination thereof, and from the configurations shown in Figs.
8a-8i, or a combination thereof.
In another embodiment, ultrasonic energy is delivered to the wound without the use of the spray, i.e., the ultrasonic energy is delivered through a medium other than a spray, including a gaseous medium, such as pure air, e.g., ambient air, where the ultrasound transducer 6 is positioned at a non-contact distance from the wound for providing a therapeutic and beneficial effect. The ultrasound waves, even without the use of a spray, destroy surface bacteria and stimulate health cell growth. This method of wound treatment is particularly advantageous on wounds for which contact with the wound should be avoided.
With reference to Fig. 10, an ultrasonic treatment system 2' is shown including an ultrasound generator 4' connected to an ultrasound transducer 6' by a cable 8' for generating ultrasound energy. Transducer 6' has a radiation surface 36' from which the ultrasound energy is emitted and directed to wound 40'. The generator 4', which is conventional, may have a front panel 10' with a power button 12', a timer 14', a control button 16', a display 18', and one or more jacks 20', for example, for connecting a footswitch. Arrows 100 represent the direction of ultrasound energy generated and directed toward wound 40'. Unlike the above embodiments, a liquid or powder is not contacted with the ultrasonic transducer for generating a spray and directing it to the wound 40'. The ultrasonic energy is delivered through a medium other than a spray, including a gaseous medium, such as pure air ("dry" approach). A horn of the transducer
Valve 34 allows liquid to flow to distal tip 36 as drops or as a continuous flow through gap 46. Valve 34 may be located anywhere, including between reservoir 32 and horn 30.
Mechanical movement of the horn 30 in the direction x-x causes liquid to flow to the distal end of radiation surface 36.
Fig. 4(a) is a view of the ultrasonic sprayer as used in accordance with the method of the present invention for spraying liquid 48 directed to distal end (radiation surface) 36.
Fig. 4(b) is a view of the basic spraying method from side (radial) surface of the tip based on the Babaev effect. In this example, liquid or drug directed to the radiation surface 36 of ultrasound horn 30 becomes sonicated (ultrasonically energized), after being pulled forward by negative pressure (vacuum) created by ultrasound waves and sprays.
As shown in Fig. 5, liquid is delivered to the side of radiation surface 36 of transducer horn 30 about the perimeter of radiation surface 36, up to 360 about its perimeter, e.g. from the top, side, bottom, etc.
In the embodiment of the invention shown in Fig. 6, a partial section of transducer horn 30 is elevated from the horizontal up to 90 . Due to the Babaev effect, liquid 48 still travels to radiation surface 36.
The ultrasound tip or horn may have a regular or irregular lateral cross-section, including circular, oval, elliptical, rectangular, trapezoidal, or a combination thereof. For example, Figs. 7(a) to 7(g) are each a view of a cross-section of an ultrasound tip or horn.
Also, the distal end shape of the ultrasound tip or horn longitudinal cross-section may vary, and may be rectangular, elliptical, oval, spherical, conical, curved, stepped, with chamfer, etc., as shown in Figs. 8(a) to 8(n), which are each an enlarged view in section of a different, exemplary modification of a tip of the sprayer as used in accordance with the method of the present invention. The preferred shape is rectangular, because radiation beams from ultrasound tip surface are substantially fully directed to the target (wound). With the spherical, elliptic and oval (Fig. 8(e)) form or shape of the distal end, radiation beams are focused at a focal point.
However, with other forms or shapes of the distal end, radiation beams are spread, thus partially reaching the target.
Radial side surface of the distal end of the tip may have a slot (groove) or thread for liquid to be directed to the radiation surface (Figs. 9a-9c).
Figs. 9a to 9c are each a view of a radial side surface of the distal end of the tip which has a slot (groove) 19 or thread 20 for liquid to be directed to the radiation surface.
The ultrasonic energy delivered has an intensity capable of providing a therapeutic effect to the wound 40, exerting acoustic pressure and/or causing micro-cavitation.
Acoustic pressure refers to a force that can be felt which is exerted through air between the transducer and the tissue being targeted. Microcavitation refers to the formation and pulsation of gas or vapor filled microscopic bubbles in fluids as a result of ultrasonically induced and regularly repeated pressure changes. Advantages to microcavitation include the creation of acoustic streaming which is a steady circulation of fluid in blood vessels induced by ultrasound radiation force.
Preferably, the amplitude achieved by the ultrasonic energy is at least 3 microns and preferably at least 10 microns. Preferably, the frequency used is in the range of 20kHz-50MHz, wherein a preferred range is 20-200kHz, a more preferred range is 20-40kHz and a most preferred value is 40kHz, wherein most preferably the lower limit of the frequency used is outside of the human hearing range.
Furthermore, it is advantageous to use a radiation surface 36 having a shape and size selected to achieve delivery of the ultrasonic energy to the wound where the delivered ultrasonic energy has an intensity capable of providing a therapeutic effect to the wound. Selection of the shape and size of the radiation surface 36 in combination with selection of the frequency and amplitude of the ultrasonic energy used is advantageous in achieving delivery of the ultrasonic energy to the wound wherein the ultrasonic energy has an intensity capable of achieving a therapeutic effect to the wound. Preferably, the radiation surface 36 has a relatively large diameter. Actual selection of the diameter is dependent upon the frequency and amplitude selected. Furthermore, the shape of the radiation surface 36 is selected from one of flat, concave, convex, or a combination thereof, and from the configurations shown in Figs.
8a-8i, or a combination thereof.
In another embodiment, ultrasonic energy is delivered to the wound without the use of the spray, i.e., the ultrasonic energy is delivered through a medium other than a spray, including a gaseous medium, such as pure air, e.g., ambient air, where the ultrasound transducer 6 is positioned at a non-contact distance from the wound for providing a therapeutic and beneficial effect. The ultrasound waves, even without the use of a spray, destroy surface bacteria and stimulate health cell growth. This method of wound treatment is particularly advantageous on wounds for which contact with the wound should be avoided.
With reference to Fig. 10, an ultrasonic treatment system 2' is shown including an ultrasound generator 4' connected to an ultrasound transducer 6' by a cable 8' for generating ultrasound energy. Transducer 6' has a radiation surface 36' from which the ultrasound energy is emitted and directed to wound 40'. The generator 4', which is conventional, may have a front panel 10' with a power button 12', a timer 14', a control button 16', a display 18', and one or more jacks 20', for example, for connecting a footswitch. Arrows 100 represent the direction of ultrasound energy generated and directed toward wound 40'. Unlike the above embodiments, a liquid or powder is not contacted with the ultrasonic transducer for generating a spray and directing it to the wound 40'. The ultrasonic energy is delivered through a medium other than a spray, including a gaseous medium, such as pure air ("dry" approach). A horn of the transducer
6' may be configured in accordance with the embodiments shown in Figs. 7a-g, 8a-i and/or 9a-c.
In a preferred embodiment of the invention, wherein the ultrasonic energy is delivered to the wound 40' through a gaseous medium, such as pure air, for achieving a therapeutic effect at the wound 40', the frequency of the ultrasonic energy generated is selected to be a low frequency. By using a low frequency, a particular or predetermined amplitude for the generated ultrasonic energy is achieved, which is capable of being delivered to the wound with an intensity capable of providing a therapeutic effect to the wound 40', exerting acoustic pressure and/or causing micro-cavitation. Preferably, the amplitude achieved by the ultrasonic energy is at least 3 microns and preferably at least 10 microns. Preferably, the frequency used is in the range of 20kHz-50MHz, wherein a preferred range is 20-200kHz, a more preferred range is 20-40kHz and a most preferred value is 40kHz, wherein most preferably the lower limit of the frequency used is outside of the human hearing range.
Furthermore, it is advantageous to use a radiation surface 36' having a shape and size selected to achieve delivery of the ultrasonic energy to the wound where the delivered ultrasonic energy has an intensity capable of providing a therapeutic effect to the wound. Selection of the shape and size of the radiation surface 36' in combination with selection of the frequency and amplitude of the ultrasonic energy used is advantageous in achieving delivery of the ultrasonic energy to the wound wherein the ultrasonic energy has an intensity capable of achieving a therapeutic effect to the wound. Preferably, the perimeter of the radiation surface 36' is round, rectangular, elliptical, oval, spherical, conical, curved, stepped, with chamfer, etc., or a combination thereof, as shown in Figs. 8(a) to 8(n), and has a relatively large diameter. Actual selection of the diameter is dependent upon the frequency and amplitude selected. Furthermore, the shape of the radiation surface 36' is selected from one of flat, concave, convex, and a combination thereof.
With respect to Fig. 11, results are shown of experimentation at Celleration Acoustic Laboratory, Eden Prairie, Minnesota. Ultrasonic energy having an intensity capable of providing a therapeutic effect was delivered through air (no spraying of liquid or powder) to a wound using an ultrasound transducer positioned at a non-contact distance from the surface of the wound, as shown by Fig. 10. The ultrasonic energy was generated at a frequency of 40kHz and an amplitude of 61 microns. The transducer radiation surface was flat, rounded and had a diameter of lcm. Hydrophone model number PVDF-Z44-1000 and hydrophone amplifier model number A17db, both manufactured by ONDA Corporation, Sunnyvale, California, were employed, using an amplifier gain of 7.44. As shown, with the transducer positioned at a distance of between 2.5mm and 38mm from a wound, ultrasonic energy was delivered to the wound having an intensity capable of providing a therapeutic effect to the wound; the intensity being within the range of from 0.1 W/cmz to 10W/cmz.
With respect to Figs. 10-11, the ultrasound energy is delivered to the wound or tissue being treated through a medium other than a spray, including a gaseous medium, such as pure air, e.g., ambient air, including without the use of the spray. Accordingly, the ultrasound energy is delivered to the tissue through a substantial expanse of a substantially purely gaseous medium, such as ambient air. Preferably, the transducer may be positioned at a non-contact distance from the tissue, where the space between the transducer and the tissue through which the ultrasound energy is delivered is an expanse of a substantially purely gaseous medium spanning a distance of at least about 0.1 in. (2.5 mm) from the transducer to the tissue.
Preferably the distance spanned is from about 0.1 in. (2.5 mm) to 20 in. (51 cm), and is more preferably from about 0.1 in. (2.5 mm) to 5 in. (12.7 cm).
The embodiment shown in Figs. 2-6 may further be used for delivering ultrasound energy to the skin without the use of a spray by not providing a liquid within the reservoir 32 so that liquid does not flow to the radiation surface 36, or by selectively controlling delivery of liquid from the reservoir to the radiation surface 36 in accordance with one or more requests from an operator and/or a control module. The operator may make a request via a selection device which may be mechanical and/or electrical, e.g., a button, trigger, lever and/or user interface. The request may be processed mechanically and/or electrically (by analog and/or digital processing) for mechanically controlling flow of the liquid, such as by controlling the valve 34 to remain open or closed or sequentially open and close, in any order. Accordingly, non-contact ultrasound treatment without a spray may be provided to tissue using either the embodiment shown in Figs 1-6 or the embodiment shown in Fig. 10.
As described further below, the reservoir may be provided in a device separate from the transducer and the spray may be generated and delivered from another device separate from the transducer, where the separate device may be detached from or attached to the transducer. The spray from the separate device may be a spray generated and delivered by another transducer or by a device that does not use ultrasound energy. Similar to the embodiment described with respect to Figs. 1-6 in which the spray is delivered simultaneously with delivery of the ultrasound energy, the spray delivered from a separate device may be delivered simultaneously with delivery of the ultrasound energy. Alternatively, the spray may be delivered prior to delivery of the ultrasound energy, as described further below. Furthermore, a treatment may include a series of continual and/or intermittent treatments, wherein individual treatments of the series of treatments are selected from the group consisting of. delivery of ultrasound energy with the use of a spray, i.e., the wet approach as described with respect to Figs.
1-6; and delivery of ultrasound energy through a medium other than a spray (i.e., a gaseous medium), i.e., the dry approach as described with respect to Fig. 10, with the two or more steps performed in any order.
Accordingly, non-contact ultrasound treatment with or without a spray may be provided to tissue using either using the embodiment described with respect to Figs. 1-6 or the embodiment shown in Fig. 10.
The liquid or powder to be sprayed (via the reservoir 32, valve 34 and radiation surface 36 shown in Figs. 1-6 or via a separate device) may be an analgesic, such as for use as a local anesthetic, such as prior to a dental procedure, suturing, or other invasive or noninvasive procedure or for relief of pain. The analgesic is sonicated, providing a more immediate effect, a more potent effect, further penetration into the skin, improved precision of dosage, and a more targeted affect for minimizing effects to untargeted tissue. Moreover, independent of the effect of the sonicated analgesic, the low frequency ultrasonic waves applied in accordance with a method of the present invention, such as through the medium of a spray formed from a saline solution, provide an analgesic effect. The combination of the sonicated analgesic and of the low frequency ultrasonic waves in accordance with a method of the present invention produce a strong local anesthetic effect not found in mere topical application of analgesics.
Another embodiment of a method of the invention includes the step of providing a substance, such as a medicament and herein referred to as medicament, for application of the medicament to tissue, and delivering ultrasound energy to the medicament as it is applied or once it is applied and to the tissue using the embodiment shown in Figs. 1-6 or the embodiment shown in Fig. 10, and the amplitude, frequency, non-contact distance and other parameters for the ultrasound energy, generator and transducer described above. The ultrasound energy is delivered by a non-contact delivery (i.e., without contacting the transducer 6 or 6' to the tissue) to the tissue, as described above, and may be delivered through a spray or without a spray, e.g., by delivering the ultrasound energy through a medium other than a spray, such as ambient air, gas, etc. The medicament is, for example, an antibiotic, an ointment, cream, gel, liquid, salve, oil, saline solution, distilled, non-distilled and/or boiled water, powder, spray, antibacterial agent, antiseptic agent, insulin, analgesic agent, conditioner, surfactant, emollient, or other active ingredient, or a combination thereof.
The medicament may be applied directly to the tissue before the ultrasound energy is delivered to the tissue, and/or during the delivery of the ultrasound energy to the tissue.
The medicament may be provided within at least one container from which the medicament is applied to the tissue, where the container is in contact with the tissue, proximate the tissue and/or spaced from the tissue and oriented for directing the medicament at the tissue. The container may have a permeable wall(s) through which the medicament may pass directly to or towards the tissue, manually, automatically and/or mechanically, and/or through which the ultrasound energy may penetrate. The container maybe integrated with or separated from the housing of the transducer 6 or 6'.
Furthermore, the medicament may be applied below the tissue in addition to or instead of to the surface of the tissue.
The various medicaments and methods for applying the medicament to the tissue may be used sequentially in any combination or sequence in conjunction with application of the ultrasound energy (delivered with and/or without the spray, or sequentially with and without the spray in any sequence). The sequence may include wait periods during which the ultrasound energy is not applied. Specifically, a treatment may include a series of treatments, wherein individual treatments of the series of treatments are selected from the group consisting of: the treatment including the steps of delivering ultrasonic energy from a non-contact distance to the tissue simultaneous with delivery of a spray to the tissue, wherein the ultrasonic energy has an intensity capable of penetrating the tissue to a beneficial depth to provide a therapeutic effect to the tissue and sonicating the spray for causing the medicament to penetrate the tissue to a beneficial depth to provide a therapeutic effect to the tissue; the treatment including the steps of delivering ultrasonic energy from a non-contact distance to the tissue through a substantial expanse of a substantially purely gaseous medium to the tissue, wherein the ultrasonic energy has an intensity capable of penetrating the tissue to a beneficial depth to provide a therapeutic effect to the tissue; and the treatment including the steps of the method of the invention, wherein a different medicament is applied.
Delivery of the ultrasound energy to the medicament and to the tissue energizes the medicament via sonication and causes penetration of the medicament into the tissue for providing an enhanced therapeutic effect to the tissue. Further, the delivery of the ultrasound energy causes exertion of acoustic pressure. The sonicated medicament and the combination of the sonicated medicament and the low frequency ultrasound waves each provide at least advantages similar to the advantages provided by the sonicated spray and the combination of the sonicated spray and low frequency ultrasound waves. Such advantages include increasing potency of the medicament, obtaining more immediate results, decreasing the volume of the medicament used relative to a volume used for a comparable treatment using traditional methods for achieving the same effect, increased precision of dosage of the medicament, re-establishment of traditional antibiotics to which bacteria have become resistant and deeper penetration into the tissue.
The substance may be applied to surfaces other than tissue for non-medical applications, such as cleansing, sterilizing and coating surfaces of objects and food.
The preceding specific embodiments are illustrative of the practice of the invention. It is to be understood, however, that other expedients known to those skilled in the art or disclosed herein, may be employed without departing from the spirit of the invention or the scope of the appended claims.
In a preferred embodiment of the invention, wherein the ultrasonic energy is delivered to the wound 40' through a gaseous medium, such as pure air, for achieving a therapeutic effect at the wound 40', the frequency of the ultrasonic energy generated is selected to be a low frequency. By using a low frequency, a particular or predetermined amplitude for the generated ultrasonic energy is achieved, which is capable of being delivered to the wound with an intensity capable of providing a therapeutic effect to the wound 40', exerting acoustic pressure and/or causing micro-cavitation. Preferably, the amplitude achieved by the ultrasonic energy is at least 3 microns and preferably at least 10 microns. Preferably, the frequency used is in the range of 20kHz-50MHz, wherein a preferred range is 20-200kHz, a more preferred range is 20-40kHz and a most preferred value is 40kHz, wherein most preferably the lower limit of the frequency used is outside of the human hearing range.
Furthermore, it is advantageous to use a radiation surface 36' having a shape and size selected to achieve delivery of the ultrasonic energy to the wound where the delivered ultrasonic energy has an intensity capable of providing a therapeutic effect to the wound. Selection of the shape and size of the radiation surface 36' in combination with selection of the frequency and amplitude of the ultrasonic energy used is advantageous in achieving delivery of the ultrasonic energy to the wound wherein the ultrasonic energy has an intensity capable of achieving a therapeutic effect to the wound. Preferably, the perimeter of the radiation surface 36' is round, rectangular, elliptical, oval, spherical, conical, curved, stepped, with chamfer, etc., or a combination thereof, as shown in Figs. 8(a) to 8(n), and has a relatively large diameter. Actual selection of the diameter is dependent upon the frequency and amplitude selected. Furthermore, the shape of the radiation surface 36' is selected from one of flat, concave, convex, and a combination thereof.
With respect to Fig. 11, results are shown of experimentation at Celleration Acoustic Laboratory, Eden Prairie, Minnesota. Ultrasonic energy having an intensity capable of providing a therapeutic effect was delivered through air (no spraying of liquid or powder) to a wound using an ultrasound transducer positioned at a non-contact distance from the surface of the wound, as shown by Fig. 10. The ultrasonic energy was generated at a frequency of 40kHz and an amplitude of 61 microns. The transducer radiation surface was flat, rounded and had a diameter of lcm. Hydrophone model number PVDF-Z44-1000 and hydrophone amplifier model number A17db, both manufactured by ONDA Corporation, Sunnyvale, California, were employed, using an amplifier gain of 7.44. As shown, with the transducer positioned at a distance of between 2.5mm and 38mm from a wound, ultrasonic energy was delivered to the wound having an intensity capable of providing a therapeutic effect to the wound; the intensity being within the range of from 0.1 W/cmz to 10W/cmz.
With respect to Figs. 10-11, the ultrasound energy is delivered to the wound or tissue being treated through a medium other than a spray, including a gaseous medium, such as pure air, e.g., ambient air, including without the use of the spray. Accordingly, the ultrasound energy is delivered to the tissue through a substantial expanse of a substantially purely gaseous medium, such as ambient air. Preferably, the transducer may be positioned at a non-contact distance from the tissue, where the space between the transducer and the tissue through which the ultrasound energy is delivered is an expanse of a substantially purely gaseous medium spanning a distance of at least about 0.1 in. (2.5 mm) from the transducer to the tissue.
Preferably the distance spanned is from about 0.1 in. (2.5 mm) to 20 in. (51 cm), and is more preferably from about 0.1 in. (2.5 mm) to 5 in. (12.7 cm).
The embodiment shown in Figs. 2-6 may further be used for delivering ultrasound energy to the skin without the use of a spray by not providing a liquid within the reservoir 32 so that liquid does not flow to the radiation surface 36, or by selectively controlling delivery of liquid from the reservoir to the radiation surface 36 in accordance with one or more requests from an operator and/or a control module. The operator may make a request via a selection device which may be mechanical and/or electrical, e.g., a button, trigger, lever and/or user interface. The request may be processed mechanically and/or electrically (by analog and/or digital processing) for mechanically controlling flow of the liquid, such as by controlling the valve 34 to remain open or closed or sequentially open and close, in any order. Accordingly, non-contact ultrasound treatment without a spray may be provided to tissue using either the embodiment shown in Figs 1-6 or the embodiment shown in Fig. 10.
As described further below, the reservoir may be provided in a device separate from the transducer and the spray may be generated and delivered from another device separate from the transducer, where the separate device may be detached from or attached to the transducer. The spray from the separate device may be a spray generated and delivered by another transducer or by a device that does not use ultrasound energy. Similar to the embodiment described with respect to Figs. 1-6 in which the spray is delivered simultaneously with delivery of the ultrasound energy, the spray delivered from a separate device may be delivered simultaneously with delivery of the ultrasound energy. Alternatively, the spray may be delivered prior to delivery of the ultrasound energy, as described further below. Furthermore, a treatment may include a series of continual and/or intermittent treatments, wherein individual treatments of the series of treatments are selected from the group consisting of. delivery of ultrasound energy with the use of a spray, i.e., the wet approach as described with respect to Figs.
1-6; and delivery of ultrasound energy through a medium other than a spray (i.e., a gaseous medium), i.e., the dry approach as described with respect to Fig. 10, with the two or more steps performed in any order.
Accordingly, non-contact ultrasound treatment with or without a spray may be provided to tissue using either using the embodiment described with respect to Figs. 1-6 or the embodiment shown in Fig. 10.
The liquid or powder to be sprayed (via the reservoir 32, valve 34 and radiation surface 36 shown in Figs. 1-6 or via a separate device) may be an analgesic, such as for use as a local anesthetic, such as prior to a dental procedure, suturing, or other invasive or noninvasive procedure or for relief of pain. The analgesic is sonicated, providing a more immediate effect, a more potent effect, further penetration into the skin, improved precision of dosage, and a more targeted affect for minimizing effects to untargeted tissue. Moreover, independent of the effect of the sonicated analgesic, the low frequency ultrasonic waves applied in accordance with a method of the present invention, such as through the medium of a spray formed from a saline solution, provide an analgesic effect. The combination of the sonicated analgesic and of the low frequency ultrasonic waves in accordance with a method of the present invention produce a strong local anesthetic effect not found in mere topical application of analgesics.
Another embodiment of a method of the invention includes the step of providing a substance, such as a medicament and herein referred to as medicament, for application of the medicament to tissue, and delivering ultrasound energy to the medicament as it is applied or once it is applied and to the tissue using the embodiment shown in Figs. 1-6 or the embodiment shown in Fig. 10, and the amplitude, frequency, non-contact distance and other parameters for the ultrasound energy, generator and transducer described above. The ultrasound energy is delivered by a non-contact delivery (i.e., without contacting the transducer 6 or 6' to the tissue) to the tissue, as described above, and may be delivered through a spray or without a spray, e.g., by delivering the ultrasound energy through a medium other than a spray, such as ambient air, gas, etc. The medicament is, for example, an antibiotic, an ointment, cream, gel, liquid, salve, oil, saline solution, distilled, non-distilled and/or boiled water, powder, spray, antibacterial agent, antiseptic agent, insulin, analgesic agent, conditioner, surfactant, emollient, or other active ingredient, or a combination thereof.
The medicament may be applied directly to the tissue before the ultrasound energy is delivered to the tissue, and/or during the delivery of the ultrasound energy to the tissue.
The medicament may be provided within at least one container from which the medicament is applied to the tissue, where the container is in contact with the tissue, proximate the tissue and/or spaced from the tissue and oriented for directing the medicament at the tissue. The container may have a permeable wall(s) through which the medicament may pass directly to or towards the tissue, manually, automatically and/or mechanically, and/or through which the ultrasound energy may penetrate. The container maybe integrated with or separated from the housing of the transducer 6 or 6'.
Furthermore, the medicament may be applied below the tissue in addition to or instead of to the surface of the tissue.
The various medicaments and methods for applying the medicament to the tissue may be used sequentially in any combination or sequence in conjunction with application of the ultrasound energy (delivered with and/or without the spray, or sequentially with and without the spray in any sequence). The sequence may include wait periods during which the ultrasound energy is not applied. Specifically, a treatment may include a series of treatments, wherein individual treatments of the series of treatments are selected from the group consisting of: the treatment including the steps of delivering ultrasonic energy from a non-contact distance to the tissue simultaneous with delivery of a spray to the tissue, wherein the ultrasonic energy has an intensity capable of penetrating the tissue to a beneficial depth to provide a therapeutic effect to the tissue and sonicating the spray for causing the medicament to penetrate the tissue to a beneficial depth to provide a therapeutic effect to the tissue; the treatment including the steps of delivering ultrasonic energy from a non-contact distance to the tissue through a substantial expanse of a substantially purely gaseous medium to the tissue, wherein the ultrasonic energy has an intensity capable of penetrating the tissue to a beneficial depth to provide a therapeutic effect to the tissue; and the treatment including the steps of the method of the invention, wherein a different medicament is applied.
Delivery of the ultrasound energy to the medicament and to the tissue energizes the medicament via sonication and causes penetration of the medicament into the tissue for providing an enhanced therapeutic effect to the tissue. Further, the delivery of the ultrasound energy causes exertion of acoustic pressure. The sonicated medicament and the combination of the sonicated medicament and the low frequency ultrasound waves each provide at least advantages similar to the advantages provided by the sonicated spray and the combination of the sonicated spray and low frequency ultrasound waves. Such advantages include increasing potency of the medicament, obtaining more immediate results, decreasing the volume of the medicament used relative to a volume used for a comparable treatment using traditional methods for achieving the same effect, increased precision of dosage of the medicament, re-establishment of traditional antibiotics to which bacteria have become resistant and deeper penetration into the tissue.
The substance may be applied to surfaces other than tissue for non-medical applications, such as cleansing, sterilizing and coating surfaces of objects and food.
The preceding specific embodiments are illustrative of the practice of the invention. It is to be understood, however, that other expedients known to those skilled in the art or disclosed herein, may be employed without departing from the spirit of the invention or the scope of the appended claims.
Claims (28)
1. An apparatus for treating a wound comprising:
means for generating ultrasonic energy; and means for delivering the generated ultrasonic energy to the wound through a gaseous medium from a non-contact distance from the surface of the wound in the absence of a coupling medium and without direct contact between the apparatus and the wound, wherein the generated ultrasonic energy has an intensity capable of penetrating the wound to a beneficial depth to provide a therapeutic effect for decreasing the healing time for the wound, and wherein the non-contact distance is at least 2.5mm from the surface of the wound.
means for generating ultrasonic energy; and means for delivering the generated ultrasonic energy to the wound through a gaseous medium from a non-contact distance from the surface of the wound in the absence of a coupling medium and without direct contact between the apparatus and the wound, wherein the generated ultrasonic energy has an intensity capable of penetrating the wound to a beneficial depth to provide a therapeutic effect for decreasing the healing time for the wound, and wherein the non-contact distance is at least 2.5mm from the surface of the wound.
2. The apparatus according to claim 2, wherein the means for generating includes means for generating the ultrasonic energy with a particular amplitude indicative of an intensity capable of achieving the therapeutic effect, wherein the particular amplitude is at least 3 microns.
3. The apparatus according to claim 2, wherein the means for generating further includes the means for generating the ultrasonic energy with a frequency capable of achieving the particular amplitude.
4. The apparatus according to claim 2, wherein the particular amplitude is at least 10 microns.
5. The apparatus according to claim 3, wherein the frequency is in the range of 20kHz-5MHz.
6. The apparatus according to claim 3, wherein the frequency is in the range of 20-200kHz.
7. The apparatus according to claim 3, wherein the frequency is in the range of 20-40kHz.
8. The apparatus according to claim 1, wherein the means for delivering includes a radiation surface having a surface area dimensioned for achieving delivery of the ultrasonic energy to the wound with an intensity capable of achieving the therapeutic effect.
9. The apparatus according to claim 1, wherein the means for delivering includes a radiation surface having a rounded perimeter for achieving delivery of the ultrasonic energy to the wound with an intensity capable of achieving the therapeutic effect.
10. The apparatus according to claim 1, wherein the means for delivering includes a radiation surface; and a selection is made of at least one of a size of a surface area of the radiation surface, a shape of a peripheral boundary of the radiation surface, a frequency of the generated ultrasonic energy, and an amplitude of the generated ultrasonic energy for achieving delivery of ultrasonic energy to the wound with an intensity capable of achieving the therapeutic effect.
11. The apparatus according to claim 1, wherein the means for delivering includes a radiation surface; and a selection is made of a combination of a size of a surface area of the radiation surface, a shape of a peripheral boundary of the radiation surface, a shape of the curvature of the radiation surface selected from one of flat, concave, convex and a combination thereof, a frequency of the generated ultrasonic energy, and an amplitude of the generated ultrasonic energy for achieving delivery of ultrasonic energy to the wound with an intensity capable of achieving the therapeutic effect.
12. The apparatus according to claim 8, wherein a radiation surface of the means for delivering is positioned from 2.5mm to 51cm from the surface of the wound.
13. The apparatus according to claim 1, wherein the means for delivering is driven by a constant or modulated frequency having a wave form selected from the group consisting of sinusoidal, rectangular, trapezoidal and triangular wave forms.
14. The apparatus according to claim 1, wherein the therapeutic effect is selected from the group consisting of increasing blood flow to the wound and stimulating cell growth.
15. The apparatus according to claim 1, wherein the gaseous medium includes a substantial expanse of a substantially purely gaseous medium.
16. The apparatus according to claim 1, wherein the non-contact distance is about 2.5mm to 51 cm from the surface of the wound.
17. An apparatus for treating a wound comprising:
means for generating ultrasonic energy having a an amplitude of at least 3 microns; and means for delivering the generated ultrasonic energy to the wound through a gaseous medium from a non-contact distance from the surface of the wound and without direct contact between an apparatus for generating and delivering ultrasonic energy and the wound or patient tissue, wherein the gaseous medium does not include a liquid spray or other coupling medium, wherein the generated ultrasonic energy has an intensity capable of penetrating the wound tissue to a beneficial depth to provide a therapeutic effect for decreasing the healing time for the wound, wherein the particular amplitude is indicative of an intensity capable of achieving the therapeutic effect, and wherein the non-contact distance is at least 2.5mm from the surface of the wound.
means for generating ultrasonic energy having a an amplitude of at least 3 microns; and means for delivering the generated ultrasonic energy to the wound through a gaseous medium from a non-contact distance from the surface of the wound and without direct contact between an apparatus for generating and delivering ultrasonic energy and the wound or patient tissue, wherein the gaseous medium does not include a liquid spray or other coupling medium, wherein the generated ultrasonic energy has an intensity capable of penetrating the wound tissue to a beneficial depth to provide a therapeutic effect for decreasing the healing time for the wound, wherein the particular amplitude is indicative of an intensity capable of achieving the therapeutic effect, and wherein the non-contact distance is at least 2.5mm from the surface of the wound.
18. An apparatus for treating a wound comprising:
means for generating ultrasonic energy having a frequency in the range of 20-200kHz and having an amplitude of at least 3 microns; and means for delivering the generated ultrasonic energy to the wound through a gaseous medium from a non-contact distance from the surface of the wound and without direct contact between an apparatus for generating and delivering ultrasonic energy and the wound or patient tissue, wherein the gaseous medium does not include a liquid spray or other coupling medium, wherein the generated ultrasonic energy has an intensity capable of penetrating the wound tissue to a beneficial depth to provide a therapeutic effect for decreasing the healing time for the wound, wherein the frequency is capable of achieving a particular amplitude indicative of an intensity capable of achieving the therapeutic effect, and wherein the non-contact distance is at least 2.5mm from the surface of the wound.
means for generating ultrasonic energy having a frequency in the range of 20-200kHz and having an amplitude of at least 3 microns; and means for delivering the generated ultrasonic energy to the wound through a gaseous medium from a non-contact distance from the surface of the wound and without direct contact between an apparatus for generating and delivering ultrasonic energy and the wound or patient tissue, wherein the gaseous medium does not include a liquid spray or other coupling medium, wherein the generated ultrasonic energy has an intensity capable of penetrating the wound tissue to a beneficial depth to provide a therapeutic effect for decreasing the healing time for the wound, wherein the frequency is capable of achieving a particular amplitude indicative of an intensity capable of achieving the therapeutic effect, and wherein the non-contact distance is at least 2.5mm from the surface of the wound.
19. An apparatus for treating a wound comprising:
means for generating ultrasonic energy having an amplitude of at least 10 microns; and means for delivering the generated ultrasonic energy to the wound through a gaseous medium from a non-contact distance from the surface of the wound and without direct contact between an apparatus for generating and delivering ultrasonic energy and the wound or patient tissue, wherein the gaseous medium does not include a liquid spray or other coupling medium, wherein the generated ultrasonic energy has an intensity capable of penetrating the wound tissue to a beneficial depth to provide a therapeutic effect for decreasing the healing time for the wound, and wherein the non-contact distance is at least 2.5mm from the surface of the wound.
means for generating ultrasonic energy having an amplitude of at least 10 microns; and means for delivering the generated ultrasonic energy to the wound through a gaseous medium from a non-contact distance from the surface of the wound and without direct contact between an apparatus for generating and delivering ultrasonic energy and the wound or patient tissue, wherein the gaseous medium does not include a liquid spray or other coupling medium, wherein the generated ultrasonic energy has an intensity capable of penetrating the wound tissue to a beneficial depth to provide a therapeutic effect for decreasing the healing time for the wound, and wherein the non-contact distance is at least 2.5mm from the surface of the wound.
20. An apparatus for treating tissue comprising:
a generator and a transducer for generating ultrasonic energy with an amplitude of at least 3 microns;
wherein the transducer delivers the ultrasonic energy to the tissue and to a medicament separately applied to the tissue from a non-contact distance from the tissue and the medicament;
and wherein the generated ultrasonic energy has an intensity capable of applying acoustic pressure and penetrating the wound tissue to a beneficial depth to provide a therapeutic effect to the tissue, and of sonicating the medicament for causing the medicament to penetrate the tissue to a beneficial depth to provide a therapeutic effect to the tissue.
a generator and a transducer for generating ultrasonic energy with an amplitude of at least 3 microns;
wherein the transducer delivers the ultrasonic energy to the tissue and to a medicament separately applied to the tissue from a non-contact distance from the tissue and the medicament;
and wherein the generated ultrasonic energy has an intensity capable of applying acoustic pressure and penetrating the wound tissue to a beneficial depth to provide a therapeutic effect to the tissue, and of sonicating the medicament for causing the medicament to penetrate the tissue to a beneficial depth to provide a therapeutic effect to the tissue.
21. The apparatus of claim 20, wherein the generator and the transducer generating ultrasonic energy with an amplitude of at least 10 microns.
22. The apparatus of claim 20, wherein the generator and the transducer generate the ultrasonic energy with a frequency capable of achieving said amplitude.
23. The apparatus of claim 22, wherein the frequency is in the range of 20 kHz - 200 kHz.
24. The apparatus of claim 22, wherein the frequency is in the range of 20 kHz - 40 kHz.
25. The apparatus according to claim 20, wherein the transducer includes a radiation surface having a surface area dimensioned for achieving delivery of the ultrasonic energy to the tissue with an intensity capable of achieving the therapeutic effect.
26. The apparatus according to claim 20, wherein the transducer includes a radiation surface having at least one of a rounded and rectangular perimeter for achieving delivery of the ultrasonic energy to the tissue with an intensity capable of achieving the therapeutic effect.
27. The apparatus according to claim 20, wherein the transducer includes a radiation surface;
and a selection is made of at least one of a size of a surface area of the radiation surface, a shape of a peripheral boundary of the radiation surface, a frequency of the generated ultrasonic energy, and an amplitude of the generated ultrasonic energy for achieving delivery of ultrasonic energy to the tissue with an intensity capable of achieving the therapeutic effect.
and a selection is made of at least one of a size of a surface area of the radiation surface, a shape of a peripheral boundary of the radiation surface, a frequency of the generated ultrasonic energy, and an amplitude of the generated ultrasonic energy for achieving delivery of ultrasonic energy to the tissue with an intensity capable of achieving the therapeutic effect.
28. The apparatus according to claim 20, wherein the transducer includes a radiation surface;
and a selection is made of a combination of a size of a surface area of the radiation surface, a shape of a peripheral boundary of the radiation surface, a shape of the curvature of the radiation surface selected from one of flat, concave, convex and a combination thereof, a frequency of the generated ultrasonic energy, and an amplitude of the generated ultrasonic energy for achieving delivery of ultrasonic energy to the tissue with an intensity capable of achieving the therapeutic effect.
and a selection is made of a combination of a size of a surface area of the radiation surface, a shape of a peripheral boundary of the radiation surface, a shape of the curvature of the radiation surface selected from one of flat, concave, convex and a combination thereof, a frequency of the generated ultrasonic energy, and an amplitude of the generated ultrasonic energy for achieving delivery of ultrasonic energy to the tissue with an intensity capable of achieving the therapeutic effect.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/409,272 | 2003-04-07 | ||
| US10/409,272 US8235919B2 (en) | 2001-01-12 | 2003-04-07 | Ultrasonic method and device for wound treatment |
| US10/815,384 | 2004-04-01 | ||
| US10/815,384 US7914470B2 (en) | 2001-01-12 | 2004-04-01 | Ultrasonic method and device for wound treatment |
| PCT/US2004/010448 WO2004091722A1 (en) | 2003-04-07 | 2004-04-05 | Ultrasonic mehod and device for wound treatment |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2521117A1 CA2521117A1 (en) | 2004-10-28 |
| CA2521117C true CA2521117C (en) | 2012-06-12 |
Family
ID=33302763
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2521117A Expired - Lifetime CA2521117C (en) | 2003-04-07 | 2004-04-05 | Ultrasnoic method and device for wound treatment |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US7914470B2 (en) |
| EP (1) | EP1617910A1 (en) |
| JP (1) | JP2007521053A (en) |
| CA (1) | CA2521117C (en) |
| WO (1) | WO2004091722A1 (en) |
Families Citing this family (62)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8235919B2 (en) * | 2001-01-12 | 2012-08-07 | Celleration, Inc. | Ultrasonic method and device for wound treatment |
| US7914470B2 (en) * | 2001-01-12 | 2011-03-29 | Celleration, Inc. | Ultrasonic method and device for wound treatment |
| US7883031B2 (en) | 2003-05-20 | 2011-02-08 | James F. Collins, Jr. | Ophthalmic drug delivery system |
| US8545463B2 (en) | 2003-05-20 | 2013-10-01 | Optimyst Systems Inc. | Ophthalmic fluid reservoir assembly for use with an ophthalmic fluid delivery device |
| US7497990B2 (en) * | 2004-12-30 | 2009-03-03 | Kimberly-Clark Worldwide Inc. | Process for the destruction of microorganisms on a product |
| US7815575B2 (en) * | 2005-05-09 | 2010-10-19 | Salutron, Inc. | Ultrasonic monitor with a biocompatible oil based transmission medium |
| DE102006027789A1 (en) * | 2005-06-09 | 2006-12-28 | Hans-Werner Bender | Multi-purpose device for treating injuries and other physical problems, comprises modules to be combined in various ways |
| US7785277B2 (en) | 2005-06-23 | 2010-08-31 | Celleration, Inc. | Removable applicator nozzle for ultrasound wound therapy device |
| US7713218B2 (en) * | 2005-06-23 | 2010-05-11 | Celleration, Inc. | Removable applicator nozzle for ultrasound wound therapy device |
| US7947010B2 (en) * | 2005-07-08 | 2011-05-24 | Depuy Products, Inc. | Composition and system for wound decontamination |
| US20070031611A1 (en) * | 2005-08-04 | 2007-02-08 | Babaev Eilaz P | Ultrasound medical stent coating method and device |
| US8277472B2 (en) * | 2005-10-13 | 2012-10-02 | Eilaz Babaev | Deflector shield for use with multiple wound care devices |
| US7943352B2 (en) * | 2006-03-29 | 2011-05-17 | Bacoustics, Llc | Apparatus and methods for vaccine development using ultrasound technology |
| US20090234252A1 (en) * | 2006-04-24 | 2009-09-17 | Bacoustics, Llc | Portable topical pain relief system |
| US20080071315A1 (en) * | 2006-08-31 | 2008-03-20 | Tamara Colette Baynham | Integrated catheter and pulse generator systems and methods |
| US9566454B2 (en) * | 2006-09-18 | 2017-02-14 | Guided Therapy Systems, Llc | Method and sysem for non-ablative acne treatment and prevention |
| US7846341B2 (en) * | 2006-12-04 | 2010-12-07 | Bacoustics, Llc | Method of ultrasonically treating a continuous flow of fluid |
| US8491521B2 (en) * | 2007-01-04 | 2013-07-23 | Celleration, Inc. | Removable multi-channel applicator nozzle |
| US20080243047A1 (en) * | 2007-03-27 | 2008-10-02 | Babaev Eilaz P | Ultrasound wound care device |
| EP2139549A1 (en) * | 2007-03-29 | 2010-01-06 | Cupola Medical Ltd | Device and system for skin treatment |
| US7896854B2 (en) * | 2007-07-13 | 2011-03-01 | Bacoustics, Llc | Method of treating wounds by creating a therapeutic solution with ultrasonic waves |
| EP2231279A1 (en) * | 2007-12-28 | 2010-09-29 | Celleration, Inc. | Methods for treating inflammatory skin disorders |
| US20090177123A1 (en) * | 2007-12-28 | 2009-07-09 | Celleration, Inc. | Methods for treating inflammatory disorders |
| US8016208B2 (en) | 2008-02-08 | 2011-09-13 | Bacoustics, Llc | Echoing ultrasound atomization and mixing system |
| US7950594B2 (en) * | 2008-02-11 | 2011-05-31 | Bacoustics, Llc | Mechanical and ultrasound atomization and mixing system |
| US7830070B2 (en) * | 2008-02-12 | 2010-11-09 | Bacoustics, Llc | Ultrasound atomization system |
| DE102008025233A1 (en) * | 2008-05-27 | 2009-12-03 | Erbe Elektromedizin Gmbh | Water jet surgical instrument for resection of tumor tissue in gastrointestinal tract, has jet-forming device arranged relative to nozzle such that fluid jet is adjusted by device with respect to expansion angle and/or discharge energy |
| WO2009151996A2 (en) * | 2008-06-09 | 2009-12-17 | Eilaz Babaev | Ultrasound liquid blade scalpel device |
| US20090306694A1 (en) * | 2008-06-10 | 2009-12-10 | Eilaz Babaev | Ultrasound Liquid Blade Scalpel Method |
| JP5597198B2 (en) * | 2008-07-14 | 2014-10-01 | アリゾナ・ボード・オブ・リージェンツ・フォー・アンド・オン・ビハーフ・オブ・アリゾナ・ステイト・ユニバーシティ | Method and device for modulating cellular activity using ultrasound |
| US20100022919A1 (en) * | 2008-07-22 | 2010-01-28 | Celleration, Inc. | Methods of Skin Grafting Using Ultrasound |
| US20110178442A1 (en) * | 2010-01-18 | 2011-07-21 | Mishelevich David J | Patient feedback for control of ultrasound deep-brain neuromodulation |
| US20110112394A1 (en) * | 2009-11-11 | 2011-05-12 | Mishelevich David J | Neuromodulation of deep-brain targets using focused ultrasound |
| US20110130615A1 (en) * | 2009-12-02 | 2011-06-02 | Mishelevich David J | Multi-modality neuromodulation of brain targets |
| US20110190668A1 (en) * | 2010-02-03 | 2011-08-04 | Mishelevich David J | Ultrasound neuromodulation of the sphenopalatine ganglion |
| US10537725B2 (en) * | 2010-03-05 | 2020-01-21 | Cornell University | Ultrasound-assisted convection enhanced delivery of compounds in vivo with a transducer cannula assembly |
| EP2485691B1 (en) | 2010-07-15 | 2020-03-18 | Eyenovia, Inc. | Ophthalmic drug delivery |
| US10154923B2 (en) | 2010-07-15 | 2018-12-18 | Eyenovia, Inc. | Drop generating device |
| CA2805635A1 (en) | 2010-07-15 | 2012-01-19 | Corinthian Ophthalmic, Inc. | Method and system for performing remote treatment and monitoring |
| WO2012009706A1 (en) | 2010-07-15 | 2012-01-19 | Corinthian Ophthalmic, Inc. | Drop generating device |
| US20120016441A1 (en) * | 2010-07-19 | 2012-01-19 | Sergei Belov | Device for electric pulse stimulation of healing of wounds |
| JP6230996B2 (en) | 2011-08-01 | 2017-11-15 | アルキオーネ・ライフサイエンシズ・インコーポレイテッドＡｌｃｙｏｎｅ Ｌｉｆｅｓｃｉｅｎｃｅｓ， Ｉｎｃ． | Microfluidic drug delivery device |
| EP2768385B1 (en) | 2011-10-21 | 2021-03-31 | Cerevast Medical, Inc. | System for direct communication |
| JP6105621B2 (en) | 2011-12-12 | 2017-03-29 | アイノビア，インコーポレイティド | Highly elastic polymer ejector mechanism, ejector apparatus and method of using them |
| US20130264397A1 (en) * | 2012-04-09 | 2013-10-10 | Stuart J. Erickson | Spray Head Improvements for an Ultrasonic Spray Coating Assembly |
| WO2014036170A1 (en) | 2012-08-29 | 2014-03-06 | Thync, Inc. | Systems and devices for coupling ultrasound energy to a body |
| AU2013361601B2 (en) | 2012-12-18 | 2018-04-19 | Alcyone Therapeutics, Inc. | Systems and methods for reducing or preventing backflow in a delivery system |
| AU2014281682B2 (en) | 2013-06-17 | 2019-03-21 | Alcyone Therapeutics, Inc. | Methods and devices for protecting catheter tips and stereotactic fixtures for microcatheters |
| EP3015108A1 (en) | 2013-06-27 | 2016-05-04 | Mitsubishi Rayon Co., Ltd. | Carbonated water-containing external preparation for promoting blood circulation, blood circulation-promoting device for same, and blood circulation-promoting method using same |
| CA2920014C (en) | 2013-07-31 | 2021-11-09 | Alcyone Lifesciences, Inc. | Systems and methods for drug delivery, treatment, and monitoring |
| US11224767B2 (en) | 2013-11-26 | 2022-01-18 | Sanuwave Health, Inc. | Systems and methods for producing and delivering ultrasonic therapies for wound treatment and healing |
| USD733321S1 (en) | 2014-01-10 | 2015-06-30 | Celleration, Inc. | Ultrasonic treatment device |
| USD733319S1 (en) | 2014-01-10 | 2015-06-30 | Celleration, Inc. | Ultrasonic treatment wand |
| KR101485591B1 (en) * | 2014-03-05 | 2015-01-22 | 재단법인 실감교류인체감응솔루션연구단 | Device, computer-readable recording medium and method for generating touch feeling by non-invasive brain stimulation using ultrasonic waves |
| US20160095477A1 (en) * | 2014-10-07 | 2016-04-07 | Christine Naughton | Skin-care device |
| US10806396B2 (en) | 2015-01-26 | 2020-10-20 | Alcyone Lifesciences, Inc. | Drug delivery methods with tracer |
| US10568642B2 (en) * | 2015-09-21 | 2020-02-25 | Qingdao Technological University | Bone surgery grinding experimental device capable of cooling and electrostatic atomization film formation |
| CN108472019A (en) | 2016-01-04 | 2018-08-31 | 亚克安娜生命科学有限公司 | Method and apparatus for treating apoplexy |
| KR101956446B1 (en) * | 2017-04-07 | 2019-03-08 | 서강대학교산학협력단 | Controlling method of light energy penetration depth using ultrasonic energy and apparatus thereof |
| CN115300226A (en) | 2017-06-10 | 2022-11-08 | 艾诺维亚股份有限公司 | Apparatus for delivering a volume of fluid to an eye |
| US20200289856A1 (en) * | 2017-09-29 | 2020-09-17 | Nippon Medical School Foundation | Ultrasonic treatment apparatus |
| CN116473590B (en) * | 2023-03-15 | 2024-01-23 | 四川大学华西医院 | Controller and wisdom enema ultrasonic therapy appearance |
Family Cites Families (241)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2534046A (en) | 1949-10-21 | 1950-12-12 | Johnson March Corp | Valve construction for proportioning devices |
| US2889852A (en) | 1957-03-11 | 1959-06-09 | James L Dunlap | Valve structures |
| US3243122A (en) | 1965-02-24 | 1966-03-29 | Alvin A Snaper | Ultrasonic spray apparatus |
| US3275059A (en) | 1965-05-10 | 1966-09-27 | Little Inc A | Nozzle system and fuel oil burner incorporating it |
| US3433226A (en) | 1965-07-21 | 1969-03-18 | Aeroprojects Inc | Vibratory catheterization apparatus and method of using |
| US3392916A (en) | 1965-12-08 | 1968-07-16 | Carl Gunnar Daniel Engstrom | Ultrasonic atomizer |
| US3504887A (en) | 1967-05-04 | 1970-04-07 | Itt | Flow control valves |
| US3561444A (en) | 1968-05-22 | 1971-02-09 | Bio Logics Inc | Ultrasonic drug nebulizer |
| US3522801A (en) | 1968-08-06 | 1970-08-04 | Hydrosonic Corp | Ultrasonic dental hygiene device |
| US3860173A (en) | 1970-02-03 | 1975-01-14 | Naoyasu Sata | Non-polluting combustion engine having ultrasonic fuel atomizer in place of carburetor |
| US3685634A (en) | 1970-06-08 | 1972-08-22 | Esab Hebe Ab | Conveyor belt for sheet metal |
| US3636947A (en) | 1970-12-03 | 1972-01-25 | Ultrasonic Systems | Ultrasonic home dental instrument and method |
| GB1382828A (en) | 1971-04-02 | 1975-02-05 | Plessey Co Ltd | Liquidspraying devices having a nozzle subjected to high-frequency vibrations |
| FR2199263A5 (en) * | 1972-09-13 | 1974-04-05 | Minerve Sa | |
| US3952918A (en) | 1974-03-18 | 1976-04-27 | Highland Laboratories | Fluid dispenser apparatus |
| US4085893A (en) | 1974-03-20 | 1978-04-25 | Durley Iii Benton A | Ultrasonic humidifiers, atomizers and the like |
| GB1496086A (en) | 1975-02-19 | 1977-12-21 | Plessey Co Ltd | Vibratory atomizer |
| US4309989A (en) | 1976-02-09 | 1982-01-12 | The Curators Of The University Of Missouri | Topical application of medication by ultrasound with coupling agent |
| US4153201A (en) | 1976-11-08 | 1979-05-08 | Sono-Tek Corporation | Transducer assembly, ultrasonic atomizer and fuel burner |
| US4301968A (en) | 1976-11-08 | 1981-11-24 | Sono-Tek Corporation | Transducer assembly, ultrasonic atomizer and fuel burner |
| US4185502A (en) * | 1977-10-11 | 1980-01-29 | Ralph Frank | Transducer coupling apparatus |
| US4192294A (en) | 1977-10-11 | 1980-03-11 | Gekhman Boris S | Method of removing concretions from the ureter |
| DE2811248C3 (en) | 1978-03-15 | 1981-11-26 | Bosch-Siemens Hausgeräte GmbH, 7000 Stuttgart | Liquid atomizer |
| IT1156812B (en) | 1978-06-09 | 1987-02-04 | Centro Speriment Metallurg | IMPROVEMENT IN THE MANUFACTURE OF ORIENTED GRAIN MAGNETIC SHEET |
| FR2443113B1 (en) | 1978-06-30 | 1985-12-06 | Deutsch Pruef Messgeraete | METHOD AND DEVICE FOR TRANSMITTING ACOUSTIC PULSES, PARTICULARLY IN THE FIELD OF ULTRA-SOUNDS, AND APPLICATION OF SUCH PULSES IN PARTICULAR TO NON-DESTRUCTIVE CONTROL OF MATERIALS |
| GB2029270B (en) | 1978-07-11 | 1982-11-03 | Plessey Co Ltd | Vibratory atomiser |
| DE2854841C2 (en) | 1978-12-19 | 1981-03-26 | Bosch-Siemens Hausgeräte GmbH, 7000 Stuttgart | Liquid atomizer, preferably inhalation device |
| JPS5848225B2 (en) | 1979-01-09 | 1983-10-27 | オムロン株式会社 | Atomization amount control method of ultrasonic liquid atomization device |
| DE7917568U1 (en) | 1979-06-19 | 1979-09-20 | Bosch-Siemens Hausgeraete Gmbh, 7000 Stuttgart | INHALATION DEVICE |
| GB2058209B (en) | 1979-09-11 | 1983-04-27 | Plessey Co Ltd | Method of producing a fuel injector for an engine |
| US4352459A (en) | 1979-11-13 | 1982-10-05 | Sono-Tek Corporation | Ultrasonic liquid atomizer having an axially-extending liquid feed passage |
| SU878268A1 (en) | 1979-11-19 | 1981-11-07 | Московское Ордена Ленина И Ордена Трудового Красного Знамени Высшее Техническое Училище Им. Н.Э.Баумана | Method of treating infected wounds |
| US4414202A (en) | 1980-02-19 | 1983-11-08 | Silvetti Anthony N | Composition for treatment of wounds |
| SU910157A1 (en) | 1980-02-29 | 1982-03-07 | Московское Ордена Ленина,Ордена Трудового Красного Знамени Высшее Техническое Училище Им.Баумана | Method of treating infected wounds |
| JPS5775663A (en) * | 1980-07-22 | 1982-05-12 | Kiichirou Sarui | Apparatus for treating dermatophytosis |
| US4582149A (en) | 1981-03-09 | 1986-04-15 | Reed Rock Bit Company | Drill bit having replaceable nozzles directing drilling fluid at a predetermined angle |
| US4643179A (en) * | 1981-03-25 | 1987-02-17 | Wang Paul Y | Wound coverings and processes for their preparation |
| FR2507086B1 (en) | 1981-06-06 | 1986-06-27 | Rowenta Werke Gmbh | LIQUID PIPING DEVICE FOR ULTRASONIC INHALATORS OR SIMILAR APPARATUS |
| NL8202263A (en) | 1981-06-06 | 1983-01-03 | Rowenta Werke Gmbh | ULTRASONORE RESPIRATOR. |
| DE3124854C2 (en) | 1981-06-24 | 1985-03-14 | Reinhard 8057 Eching Mühlbauer | High pressure injection system with ultrasonic atomization |
| BR8107560A (en) | 1981-11-19 | 1983-07-05 | Luiz Romariz Duarte | ULTRASONIC STIMULATION OF BONE FRACTURE CONSOLIDATION |
| SU1106485A1 (en) * | 1982-10-22 | 1984-08-07 | Московское Ордена Ленина, Ордена Октябрьской Революции И Ордена Трудового Красного Знамени Высшее Техническое Училище Им. Н.Э.Баумана | Method of treating infected wounds |
| US4541564A (en) | 1983-01-05 | 1985-09-17 | Sono-Tek Corporation | Ultrasonic liquid atomizer, particularly for high volume flow rates |
| US4655393A (en) | 1983-01-05 | 1987-04-07 | Sonotek Corporation | High volume ultrasonic liquid atomizer |
| GB8316051D0 (en) | 1983-06-13 | 1983-07-20 | Shell Int Research | Atomiser |
| EP0156409A3 (en) * | 1984-02-23 | 1986-06-25 | Jean Michel Anthony | Device for moistening parts of the human body |
| JPS60222552A (en) | 1984-04-19 | 1985-11-07 | Toa Nenryo Kogyo Kk | Ultrasonic injection method and injection valve |
| DE3574344D1 (en) | 1984-08-29 | 1989-12-28 | Omron Tateisi Electronics Co | Ultrasonic atomizer |
| DE3582287D1 (en) | 1984-09-07 | 1991-05-02 | Omron Tateisi Electronics Co | VIBRATION GENERATOR FOR AN INHALATION DEVICE WITH ULTRASONIC SPRAYING. |
| US4582654A (en) | 1984-09-12 | 1986-04-15 | Varian Associates, Inc. | Nebulizer particularly adapted for analytical purposes |
| US4726523A (en) | 1984-12-11 | 1988-02-23 | Toa Nenryo Kogyo Kabushiki Kaisha | Ultrasonic injection nozzle |
| JPS61138558A (en) | 1984-12-11 | 1986-06-26 | Toa Nenryo Kogyo Kk | Oscillator for ultrasonic wave injection nozzle |
| JPS61138559A (en) | 1984-12-11 | 1986-06-26 | Toa Nenryo Kogyo Kk | Oscillator for ultrasonic wave injection nozzle |
| EP0200258A3 (en) * | 1985-04-29 | 1988-02-03 | Jean Michel Anthony | Ultrasonic spraying device |
| JPS61259784A (en) | 1985-05-13 | 1986-11-18 | Toa Nenryo Kogyo Kk | Vibrator for ultrasonic injection |
| US4642581A (en) | 1985-06-21 | 1987-02-10 | Sono-Tek Corporation | Ultrasonic transducer drive circuit |
| US4659014A (en) | 1985-09-05 | 1987-04-21 | Delavan Corporation | Ultrasonic spray nozzle and method |
| US4883045A (en) | 1985-09-26 | 1989-11-28 | Erwin Theisz | Method for controlling growth of tissue cells |
| US4941618A (en) | 1986-07-07 | 1990-07-17 | Leeman Labs Inc. | Nebulizer employing a fine mesh screen |
| US4767402A (en) | 1986-07-08 | 1988-08-30 | Massachusetts Institute Of Technology | Ultrasound enhancement of transdermal drug delivery |
| DE3627222A1 (en) | 1986-08-11 | 1988-02-18 | Siemens Ag | ULTRASONIC POCKET SPRAYER |
| US5104042A (en) | 1986-08-27 | 1992-04-14 | Atochem North America, Inc. | Ultrasonic dispersion nozzle with internal shut-off mechanism having barrier-fluid separation means incorporated therewith |
| US4930700A (en) | 1986-08-27 | 1990-06-05 | Atochem North America | Ultrasonic dispersion nozzle having internal shut-off mechanism with barrier fluid separation |
| US4818697A (en) | 1986-10-27 | 1989-04-04 | Life Resonances, Inc. | Techniques for enhancing the permeability of ions through membranes |
| US5143588A (en) | 1986-10-27 | 1992-09-01 | Life Resonances, Inc. | Techniques for enhancing the permeability of ions through membranes |
| US4850534A (en) | 1987-05-30 | 1989-07-25 | Tdk Corporation | Ultrasonic wave nebulizer |
| US5040537A (en) | 1987-11-24 | 1991-08-20 | Hitachi, Ltd. | Method and apparatus for the measurement and medical treatment using an ultrasonic wave |
| DE3741201A1 (en) | 1987-12-02 | 1989-06-15 | Schering Ag | ULTRASONIC PROCESS AND METHOD FOR IMPLEMENTING IT |
| FI82808C (en) | 1987-12-31 | 1991-04-25 | Etelae Haemeen Keuhkovammayhdi | Ultraljudfinfördelningsanordning |
| US4905671A (en) | 1988-01-11 | 1990-03-06 | Dornier Medizintechnik Gmbh | Inducement of bone growth by acoustic shock waves |
| US5211160A (en) | 1988-09-14 | 1993-05-18 | Interpore Orthopaedics, Inc. | Ultrasonic orthopedic treatment head and body-mounting means therefor |
| US5186162A (en) | 1988-09-14 | 1993-02-16 | Interpore Orthopaedics, Inc. | Ultrasonic transducer device for treatment of living tissue and/or cells |
| EP0373237A1 (en) | 1988-12-13 | 1990-06-20 | Siemens Aktiengesellschaft | Pocket inhaler device |
| US4982730A (en) | 1988-12-21 | 1991-01-08 | Lewis Jr Royce C | Ultrasonic wound cleaning method and apparatus |
| FR2643252B1 (en) | 1989-02-21 | 1991-06-07 | Technomed Int Sa | APPARATUS FOR THE SELECTIVE DESTRUCTION OF CELLS INCLUDING SOFT TISSUES AND BONES WITHIN THE BODY OF A LIVING BODY BY IMPLOSION OF GAS BUBBLES |
| JPH03504821A (en) | 1989-03-27 | 1991-10-24 | アゼルバイジャンスキ ポリテフニチェスキ インスティテュト イメニ チェー．イルドリマ | Liquid ultrasonic atomization device |
| JPH03505424A (en) | 1989-04-14 | 1991-11-28 | アゼルバイジャンスキ ポリテフニチェスキ インスティテュト イメニ チェー．イルドリマ | Ultrasonic atomization device for liquid media |
| DE3915384C2 (en) | 1989-05-11 | 1994-05-11 | Dornier Medizintechnik | Location kinematics for a lithotripter |
| US5002059A (en) | 1989-07-26 | 1991-03-26 | Boston Scientific Corporation | Tip filled ultrasound catheter |
| US5013241A (en) | 1989-09-18 | 1991-05-07 | Von Gutfeld Robert J | Ultrasonic jet dental tool and method |
| US5163433A (en) | 1989-11-01 | 1992-11-17 | Olympus Optical Co., Ltd. | Ultrasound type treatment apparatus |
| US4961885A (en) | 1989-11-24 | 1990-10-09 | Elecsys Ltd. | Ultrasonic nebulizer |
| FR2655279B1 (en) | 1989-12-01 | 1993-09-17 | Anios Lab Sarl | PROCESS FOR MICRO-SPRAYING AN ULTRA-SOUND SOLUTION AND MICRO-DROPLET DIFFUSER IMPLEMENTING SAID DEVICE. |
| US5115805A (en) | 1990-02-23 | 1992-05-26 | Cygnus Therapeutic Systems | Ultrasound-enhanced delivery of materials into and through the skin |
| US5231975A (en) | 1990-02-23 | 1993-08-03 | Cygnus Therapeutic Systems | Ultrasound-enhanced delivery of materials into and through the skin |
| US5197946A (en) | 1990-06-27 | 1993-03-30 | Shunro Tachibana | Injection instrument with ultrasonic oscillating element |
| GB9015077D0 (en) | 1990-07-09 | 1990-08-29 | Riker Laboratories Inc | Inhaler |
| US5172692A (en) | 1990-12-05 | 1992-12-22 | Kulow Howard H | Method for inflammatory response management |
| US5269291A (en) | 1990-12-10 | 1993-12-14 | Coraje, Inc. | Miniature ultrasonic transducer for plaque ablation |
| US5324255A (en) | 1991-01-11 | 1994-06-28 | Baxter International Inc. | Angioplasty and ablative devices having onboard ultrasound components and devices and methods for utilizing ultrasound to treat or prevent vasopasm |
| WO1994016759A1 (en) | 1991-03-05 | 1994-08-04 | Miris Medical Corporation | An automatic aerosol medication delivery system and methods |
| US5316000A (en) | 1991-03-05 | 1994-05-31 | Technomed International (Societe Anonyme) | Use of at least one composite piezoelectric transducer in the manufacture of an ultrasonic therapy apparatus for applying therapy, in a body zone, in particular to concretions, to tissue, or to bones, of a living being and method of ultrasonic therapy |
| US5192312A (en) * | 1991-03-05 | 1993-03-09 | Colorado State University Research Foundation | Treated tissue for implantation and methods of treatment and use |
| CA2063529A1 (en) | 1991-03-22 | 1992-09-23 | Katsuro Tachibana | Booster for therapy of diseases with ultrasound and pharmaceutical liquid composition containing the same |
| US5325860A (en) | 1991-11-08 | 1994-07-05 | Mayo Foundation For Medical Education And Research | Ultrasonic and interventional catheter and method |
| GB2265845B (en) | 1991-11-12 | 1996-05-01 | Medix Ltd | A nebuliser and nebuliser control system |
| US5374266A (en) | 1991-11-27 | 1994-12-20 | Kabushiki Kaisha Morita Seisakusho | Medical laser treatment device |
| US5529572A (en) | 1992-01-24 | 1996-06-25 | Medispec Ltd. | Method and apparatus particularly useful for treating osteoporosis |
| SE469778B (en) * | 1992-02-17 | 1993-09-13 | Bertil Olsson Enheten Foer Kar | Apparatus for arterial reperfusion by noninvasive ultrasound effect |
| US5993389A (en) | 1995-05-22 | 1999-11-30 | Ths International, Inc. | Devices for providing acoustic hemostasis |
| US5259384A (en) | 1992-07-30 | 1993-11-09 | Kaufman Jonathan J | Ultrasonic bone-assessment apparatus and method |
| US5309898A (en) | 1992-07-30 | 1994-05-10 | Kaufman Jonathan J | Ultrasonic bone-therapy and assessment apparatus and method |
| GB2269766B (en) * | 1992-08-18 | 1996-03-13 | Shop Vac Corp | Multiple spray pattern nozzle assembly |
| US5362309A (en) | 1992-09-14 | 1994-11-08 | Coraje, Inc. | Apparatus and method for enhanced intravascular phonophoresis including dissolution of intravascular blockage and concomitant inhibition of restenosis |
| US5318014A (en) | 1992-09-14 | 1994-06-07 | Coraje, Inc. | Ultrasonic ablation/dissolution transducer |
| DE69331692T2 (en) | 1992-09-16 | 2002-10-24 | Hitachi Ltd | ULTRASCHALLBESTRAHLUNGSGERAET |
| US5314441A (en) | 1992-10-16 | 1994-05-24 | International Technidyne Corporation | Disposable slicing lancet assembly |
| US5393296A (en) | 1992-12-09 | 1995-02-28 | Siemens Aktiengesellschaft | Method for the medical treatment of pathologic bone |
| US5573497A (en) | 1994-11-30 | 1996-11-12 | Technomed Medical Systems And Institut National | High-intensity ultrasound therapy method and apparatus with controlled cavitation effect and reduced side lobes |
| US6098620A (en) | 1993-01-29 | 2000-08-08 | Aradigm Corporation | Device for aerosolizing narcotics |
| US5558085A (en) | 1993-01-29 | 1996-09-24 | Aradigm Corporation | Intrapulmonary delivery of peptide drugs |
| US5707403A (en) | 1993-02-24 | 1998-01-13 | Star Medical Technologies, Inc. | Method for the laser treatment of subsurface blood vessels |
| US5527350A (en) | 1993-02-24 | 1996-06-18 | Star Medical Technologies, Inc. | Pulsed infrared laser treatment of psoriasis |
| DE4315282C2 (en) | 1993-05-07 | 1999-10-07 | Siemens Ag | Use of an acoustic pressure pulse source |
| JP3553599B2 (en) | 1993-06-29 | 2004-08-11 | インジェット ディジタル エアロソルズ リミテッド | dispenser |
| CH686872A5 (en) | 1993-08-09 | 1996-07-31 | Disetronic Ag | Medical Inhalationsgeraet. |
| GB9324250D0 (en) | 1993-11-25 | 1994-01-12 | Minnesota Mining & Mfg | Inhaler |
| EP0657226B1 (en) | 1993-12-10 | 1998-02-04 | Siemens Aktiengesellschaft | Ultrasonic sprayer |
| US5570682A (en) | 1993-12-14 | 1996-11-05 | Ethex International, Inc. | Passive inspiratory nebulizer system |
| JPH07171150A (en) | 1993-12-20 | 1995-07-11 | Fuji Photo Optical Co Ltd | Internally inserting type ultrasonic inspecting device |
| JPH07184907A (en) | 1993-12-28 | 1995-07-25 | Toshiba Corp | Ultrasonic treating device |
| US5616140A (en) | 1994-03-21 | 1997-04-01 | Prescott; Marvin | Method and apparatus for therapeutic laser treatment |
| US5989245A (en) | 1994-03-21 | 1999-11-23 | Prescott; Marvin A. | Method and apparatus for therapeutic laser treatment |
| US5437606A (en) | 1994-03-28 | 1995-08-01 | Tsukamoto; Kenichi | Ultrasonic system to alleviate toothaches |
| US5516043A (en) | 1994-06-30 | 1996-05-14 | Misonix Inc. | Ultrasonic atomizing device |
| US5807285A (en) * | 1994-08-18 | 1998-09-15 | Ethicon-Endo Surgery, Inc. | Medical applications of ultrasonic energy |
| US6113570A (en) | 1994-09-09 | 2000-09-05 | Coraje, Inc. | Method of removing thrombosis in fistulae |
| US5547459A (en) | 1994-10-25 | 1996-08-20 | Orthologic Corporation | Ultrasonic bone-therapy apparatus and method |
| US5520612A (en) | 1994-12-30 | 1996-05-28 | Exogen, Inc. | Acoustic system for bone-fracture therapy |
| US5556372A (en) | 1995-02-15 | 1996-09-17 | Exogen, Inc. | Apparatus for ultrasonic bone treatment |
| US5626554A (en) | 1995-02-21 | 1997-05-06 | Exogen, Inc. | Gel containment structure |
| US6014970A (en) | 1998-06-11 | 2000-01-18 | Aerogen, Inc. | Methods and apparatus for storing chemical compounds in a portable inhaler |
| US5554172A (en) | 1995-05-09 | 1996-09-10 | The Larren Corporation | Directed energy surgical method and assembly |
| US5730705A (en) | 1995-06-12 | 1998-03-24 | Talish; Roger J. | Ultrasonic treatment for bony ingrowth |
| US5879376A (en) | 1995-07-12 | 1999-03-09 | Luxar Corporation | Method and apparatus for dermatology treatment |
| US5658323A (en) | 1995-07-12 | 1997-08-19 | Miller; Iain D. | Method and apparatus for dermatology treatment |
| US6041253A (en) * | 1995-12-18 | 2000-03-21 | Massachusetts Institute Of Technology | Effect of electric field and ultrasound for transdermal drug delivery |
| US5947921A (en) | 1995-12-18 | 1999-09-07 | Massachusetts Institute Of Technology | Chemical and physical enhancers and ultrasound for transdermal drug delivery |
| US5611993A (en) * | 1995-08-25 | 1997-03-18 | Areopag Usa, Inc. | Ultrasonic method of treating a continuous flow of fluid |
| US5688224A (en) | 1995-10-16 | 1997-11-18 | Precision Optics Corporation | Medical visualization device |
| US5618275A (en) | 1995-10-27 | 1997-04-08 | Sonex International Corporation | Ultrasonic method and apparatus for cosmetic and dermatological applications |
| US5735811A (en) | 1995-11-30 | 1998-04-07 | Pharmasonics, Inc. | Apparatus and methods for ultrasonically enhanced fluid delivery |
| US5725494A (en) | 1995-11-30 | 1998-03-10 | Pharmasonics, Inc. | Apparatus and methods for ultrasonically enhanced intraluminal therapy |
| ZA969680B (en) | 1995-12-21 | 1997-06-12 | Kimberly Clark Co | Ultrasonic liquid fuel injection on apparatus and method |
| US5683432A (en) | 1996-01-11 | 1997-11-04 | Medtronic, Inc. | Adaptive, performance-optimizing communication system for communicating with an implanted medical device |
| JP3930052B2 (en) | 1996-02-15 | 2007-06-13 | バイオセンス・インコーポレイテッド | Catheter-based surgery |
| US5664570A (en) | 1996-02-20 | 1997-09-09 | Svc | Apparatus for applying high-intensity ultrasonic waves to a target volume within a human or animal body |
| US5895362A (en) | 1996-02-23 | 1999-04-20 | Abbott Laboratories | Transdermal transport using ultrasonic standing waves |
| NL1002524C2 (en) | 1996-03-04 | 1997-09-05 | Gastec Nv | Catalyst for the selective oxidation of sulfur compounds to elemental sulfur, process for the preparation of such a catalyst and method for the selective oxidation of sulfur compounds elemental sulfur. |
| US5762616A (en) | 1996-03-15 | 1998-06-09 | Exogen, Inc. | Apparatus for ultrasonic treatment of sites corresponding to the torso |
| US5656016A (en) | 1996-03-18 | 1997-08-12 | Abbott Laboratories | Sonophoretic drug delivery system |
| US5630828A (en) | 1996-04-17 | 1997-05-20 | International Techndyne Corporation | Low cost disposable lancet |
| US5746756A (en) | 1996-06-03 | 1998-05-05 | Ethicon Endo-Surgery, Inc. | Internal ultrasonic tip amplifier |
| US5699805A (en) | 1996-06-20 | 1997-12-23 | Mayo Foundation For Medical Education And Research | Longitudinal multiplane ultrasound transducer underfluid catheter system |
| US6234990B1 (en) | 1996-06-28 | 2001-05-22 | Sontra Medical, Inc. | Ultrasound enhancement of transdermal transport |
| US6024718A (en) | 1996-09-04 | 2000-02-15 | The Regents Of The University Of California | Intraluminal directed ultrasound delivery device |
| US5835678A (en) | 1996-10-03 | 1998-11-10 | Emcore Corporation | Liquid vaporizer system and method |
| AU743174B2 (en) | 1997-10-08 | 2002-01-17 | Sepracor, Inc. | Dosage form for aerosol administration |
| EP0957980A4 (en) | 1996-11-27 | 2000-03-29 | Gen Hospital Corp | Compound delivery using impulse transients |
| US5875976A (en) * | 1996-12-24 | 1999-03-02 | Medi-Ject Corporation | Locking mechanism for nozzle assembly |
| US5785972A (en) | 1997-01-10 | 1998-07-28 | Tyler; Kathleen A. | Colloidal silver, honey, and helichrysum oil antiseptic composition and method of application |
| US5904659A (en) | 1997-02-14 | 1999-05-18 | Exogen, Inc. | Ultrasonic treatment for wounds |
| ATE258453T1 (en) | 1997-04-18 | 2004-02-15 | Exogen Inc | DEVICE FOR ULTRASONIC BONE TREATMENT |
| WO1998048711A1 (en) | 1997-05-01 | 1998-11-05 | Ekos Corporation | Ultrasound catheter |
| DE19718511C5 (en) | 1997-05-02 | 2010-10-21 | Sanuwave, Inc., | Device for the application of acoustic shock waves |
| DE19718513C5 (en) | 1997-05-02 | 2010-06-02 | Sanuwave, Inc., | Device for generating acoustic shock waves, in particular for medical use |
| EP1005628B1 (en) | 1997-06-19 | 2008-03-05 | Mahesh C. Bhardwaj | Ultrasonic transducer for high transduction in gases and method for non-contact ultrasound transmission into solid materials |
| US5879314A (en) | 1997-06-30 | 1999-03-09 | Cybersonics, Inc. | Transducer assembly and method for coupling ultrasonic energy to a body for thrombolysis of vascular thrombi |
| DE19733838C2 (en) | 1997-08-04 | 2001-06-13 | Hmt Ag | Device for treatment with acoustic shock waves |
| US20050003008A1 (en) * | 1997-09-23 | 2005-01-06 | Natalya Rapoport | Method of in vivo drug targeting to solid tumors via acoustically triggered drug delivery in polymeric micelles |
| US6113558A (en) | 1997-09-29 | 2000-09-05 | Angiosonics Inc. | Pulsed mode lysis method |
| US5954047A (en) | 1997-10-17 | 1999-09-21 | Systemic Pulmonary Development, Ltd. | Methods and apparatus for delivering aerosolized medication |
| US6007499A (en) | 1997-10-31 | 1999-12-28 | University Of Washington | Method and apparatus for medical procedures using high-intensity focused ultrasound |
| US7010369B2 (en) | 1997-11-07 | 2006-03-07 | Hill-Rom Services, Inc. | Medical equipment controller |
| US6325769B1 (en) | 1998-12-29 | 2001-12-04 | Collapeutics, Llc | Method and apparatus for therapeutic treatment of skin |
| US6104952A (en) | 1998-01-07 | 2000-08-15 | Tu; Lily Chen | Devices for treating canker sores, tissues and methods thereof |
| US6190315B1 (en) | 1998-01-08 | 2001-02-20 | Sontra Medical, Inc. | Sonophoretic enhanced transdermal transport |
| US6158431A (en) | 1998-02-13 | 2000-12-12 | Tsi Incorporated | Portable systems and methods for delivery of therapeutic material to the pulmonary system |
| US6102298A (en) | 1998-02-23 | 2000-08-15 | The Procter & Gamble Company | Ultrasonic spray coating application system |
| US6296630B1 (en) | 1998-04-08 | 2001-10-02 | Biocardia, Inc. | Device and method to slow or stop the heart temporarily |
| US6206842B1 (en) | 1998-08-03 | 2001-03-27 | Lily Chen Tu | Ultrasonic operation device |
| US6458109B1 (en) * | 1998-08-07 | 2002-10-01 | Hill-Rom Services, Inc. | Wound treatment apparatus |
| US6106547A (en) | 1998-09-22 | 2000-08-22 | Huei-Jung; Lien | Hot/cold dual-mold skin treatment apparatus |
| US6061597A (en) | 1998-12-18 | 2000-05-09 | Robert D. Rieman | Method and device for healing bone fractures |
| US6231528B1 (en) | 1999-01-15 | 2001-05-15 | Jonathan J. Kaufman | Ultrasonic and growth factor bone-therapy: apparatus and method |
| US6206843B1 (en) | 1999-01-28 | 2001-03-27 | Ultra Cure Ltd. | Ultrasound system and methods utilizing same |
| JP2000237275A (en) | 1999-02-24 | 2000-09-05 | Ya Man Ltd | Ultrasonic mist generating apparatus |
| US6158388A (en) | 1999-04-26 | 2000-12-12 | Wenstrand; Thomas W. | Watering attachment for cage for baby fowl |
| US6217530B1 (en) * | 1999-05-14 | 2001-04-17 | University Of Washington | Ultrasonic applicator for medical applications |
| US6209843B1 (en) * | 1999-06-14 | 2001-04-03 | R. Brantley Smith, Jr. | Pivotal rocking chair base |
| US6254294B1 (en) | 1999-08-09 | 2001-07-03 | Sigrid G. Muhar | Pharmaceutical kit |
| US20030236539A1 (en) * | 1999-10-05 | 2003-12-25 | Omnisonics Medical Technologies, Inc. | Apparatus and method for using an ultrasonic probe to clear a vascular access device |
| EP1094506A3 (en) | 1999-10-18 | 2004-03-03 | Applied Materials, Inc. | Capping layer for extreme low dielectric constant films |
| US6314318B1 (en) | 2000-01-20 | 2001-11-06 | Norman C. Petty | Device and method for treating infection using standing radio frequency waves |
| US6868289B2 (en) * | 2002-10-02 | 2005-03-15 | Standen Ltd. | Apparatus for treating a tumor or the like and articles incorporating the apparatus for treatment of the tumor |
| RU2160138C1 (en) * | 2000-07-10 | 2000-12-10 | Закрытое акционерное общество "ЭКОИНВЕНТ" | Method and device for therapeutic influence on biologic tissues by ultrasonic field |
| AU2001288383A1 (en) * | 2000-08-24 | 2002-03-26 | Encapsulation Systems, Inc. | Ultrasonically enhanced substance delivery system and device |
| AU2001293112A1 (en) | 2000-09-25 | 2002-04-02 | Advanced Medical Applications, Inc. | Ultrasonic method and device for wound treatment |
| US6964647B1 (en) | 2000-10-06 | 2005-11-15 | Ellaz Babaev | Nozzle for ultrasound wound treatment |
| US6601581B1 (en) | 2000-11-01 | 2003-08-05 | Advanced Medical Applications, Inc. | Method and device for ultrasound drug delivery |
| DE20019711U1 (en) | 2000-11-20 | 2002-04-04 | Soering Gmbh | Ultrasound device for the treatment of septic wounds |
| US6916296B2 (en) | 2000-11-20 | 2005-07-12 | Soring Gmbh Medizintechnik | System for antiseptic surgery |
| US6412905B1 (en) | 2000-12-21 | 2002-07-02 | Acer Communications And Multimedia | Ink jet cap with vent |
| US6533803B2 (en) | 2000-12-22 | 2003-03-18 | Advanced Medical Applications, Inc. | Wound treatment method and device with combination of ultrasound and laser energy |
| US6761729B2 (en) | 2000-12-22 | 2004-07-13 | Advanced Medicalapplications, Inc. | Wound treatment method and device with combination of ultrasound and laser energy |
| US6569099B1 (en) * | 2001-01-12 | 2003-05-27 | Eilaz Babaev | Ultrasonic method and device for wound treatment |
| US7914470B2 (en) * | 2001-01-12 | 2011-03-29 | Celleration, Inc. | Ultrasonic method and device for wound treatment |
| US8235919B2 (en) | 2001-01-12 | 2012-08-07 | Celleration, Inc. | Ultrasonic method and device for wound treatment |
| IL141123A0 (en) | 2001-01-26 | 2002-02-10 | Iger Yoni | Method and apparatus for the delivery of substances to biological components |
| US6960173B2 (en) | 2001-01-30 | 2005-11-01 | Eilaz Babaev | Ultrasound wound treatment method and device using standing waves |
| WO2002069821A1 (en) * | 2001-03-06 | 2002-09-12 | Thermemed Corp. | Vaporous delivery of thermal energy to tissue sites |
| US6559365B2 (en) | 2001-03-06 | 2003-05-06 | Hans-Peter Wilfer | Stand |
| US6623444B2 (en) | 2001-03-21 | 2003-09-23 | Advanced Medical Applications, Inc. | Ultrasonic catheter drug delivery method and device |
| US6478754B1 (en) * | 2001-04-23 | 2002-11-12 | Advanced Medical Applications, Inc. | Ultrasonic method and device for wound treatment |
| JP4660024B2 (en) * | 2001-06-26 | 2011-03-30 | 帝人株式会社 | MMP activity lowering apparatus and method |
| US6533484B1 (en) | 2001-09-13 | 2003-03-18 | Allegiance Corporation | Solution applicator |
| US7431711B2 (en) | 2001-11-21 | 2008-10-07 | Hydrocision, Inc. | Liquid jet surgical instruments incorporating channel openings aligned along the jet beam |
| US6732744B2 (en) | 2001-12-07 | 2004-05-11 | The Procter & Gamble Company | Method for the ultrasonic treatment of hair and other keratinous fibers |
| US20040073175A1 (en) * | 2002-01-07 | 2004-04-15 | Jacobson James D. | Infusion system |
| US6666431B2 (en) | 2002-02-11 | 2003-12-23 | Mccusker Leo | Remote water control valve |
| US20040028552A1 (en) | 2002-03-20 | 2004-02-12 | Bhardwaj Mahesh C. | Gas contact ultrasound germicide and therapeutic treatment |
| US20040034982A1 (en) | 2002-07-30 | 2004-02-26 | L&L Products, Inc. | System and method for sealing, baffling or reinforcing |
| US20040030254A1 (en) | 2002-08-07 | 2004-02-12 | Eilaz Babaev | Device and method for ultrasound wound debridement |
| US6752015B2 (en) | 2002-09-24 | 2004-06-22 | Visteon Global Technologies, Inc. | Fluid flow device having reduced fluid ingress |
| US7316664B2 (en) | 2002-10-21 | 2008-01-08 | Advanced Medical Optics, Inc. | Modulated pulsed ultrasonic power delivery system and method |
| US7567581B2 (en) | 2002-10-21 | 2009-07-28 | Broadcom Corporation | Multi-service channelized SONET mapper framer |
| US7377905B2 (en) * | 2003-10-01 | 2008-05-27 | Robert Vago | Method and device for subaqueous ultrasonic irradiation of living tissue |
| JP4498148B2 (en) | 2004-02-12 | 2010-07-07 | キヤノン株式会社 | Liquid applicator, recording device |
| US7785277B2 (en) | 2005-06-23 | 2010-08-31 | Celleration, Inc. | Removable applicator nozzle for ultrasound wound therapy device |
| US7713218B2 (en) | 2005-06-23 | 2010-05-11 | Celleration, Inc. | Removable applicator nozzle for ultrasound wound therapy device |
| DE102005029746B4 (en) * | 2005-06-24 | 2017-10-26 | Boehringer Ingelheim International Gmbh | atomizer |
| US7662177B2 (en) * | 2006-04-12 | 2010-02-16 | Bacoustics, Llc | Apparatus and methods for pain relief using ultrasound waves in combination with cryogenic energy |
| AU2007286660A1 (en) * | 2006-08-25 | 2008-02-28 | Eilaz Babaev | Portable ultrasound device for the treatment of wounds |
| US8038622B2 (en) * | 2007-08-03 | 2011-10-18 | Innoscion, Llc | Wired and wireless remotely controlled ultrasonic transducer and imaging apparatus |
| US20080177221A1 (en) | 2006-12-22 | 2008-07-24 | Celleration, Inc. | Apparatus to prevent applicator re-use |
| WO2008085911A1 (en) | 2007-01-04 | 2008-07-17 | Celleration, Inc. | Removable multi-channel applicator nozzle |
| US8491521B2 (en) | 2007-01-04 | 2013-07-23 | Celleration, Inc. | Removable multi-channel applicator nozzle |
| US7901388B2 (en) * | 2007-07-13 | 2011-03-08 | Bacoustics, Llc | Method of treating wounds by creating a therapeutic solution with ultrasonic waves |
| US7896854B2 (en) * | 2007-07-13 | 2011-03-01 | Bacoustics, Llc | Method of treating wounds by creating a therapeutic solution with ultrasonic waves |
| US20100022919A1 (en) * | 2008-07-22 | 2010-01-28 | Celleration, Inc. | Methods of Skin Grafting Using Ultrasound |
| US8323220B2 (en) * | 2008-09-19 | 2012-12-04 | Eilaz Babaev | Spider vein treatment apparatus |
-
2004
- 2004-04-01 US US10/815,384 patent/US7914470B2/en not_active Expired - Lifetime
- 2004-04-05 JP JP2006509708A patent/JP2007521053A/en active Pending
- 2004-04-05 WO PCT/US2004/010448 patent/WO2004091722A1/en active Application Filing
- 2004-04-05 CA CA2521117A patent/CA2521117C/en not_active Expired - Lifetime
- 2004-04-05 EP EP04749758A patent/EP1617910A1/en not_active Withdrawn
-
2011
- 2011-03-28 US US13/073,863 patent/US20110230795A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA2521117A1 (en) | 2004-10-28 |
| US20110230795A1 (en) | 2011-09-22 |
| EP1617910A1 (en) | 2006-01-25 |
| WO2004091722A8 (en) | 2006-05-18 |
| JP2007521053A (en) | 2007-08-02 |
| US20040186384A1 (en) | 2004-09-23 |
| WO2004091722A1 (en) | 2004-10-28 |
| US7914470B2 (en) | 2011-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2521117C (en) | Ultrasnoic method and device for wound treatment | |
| US6569099B1 (en) | Ultrasonic method and device for wound treatment | |
| US8235919B2 (en) | Ultrasonic method and device for wound treatment | |
| US6478754B1 (en) | Ultrasonic method and device for wound treatment | |
| US6533803B2 (en) | Wound treatment method and device with combination of ultrasound and laser energy | |
| US6761729B2 (en) | Wound treatment method and device with combination of ultrasound and laser energy | |
| US7713218B2 (en) | Removable applicator nozzle for ultrasound wound therapy device | |
| US6960173B2 (en) | Ultrasound wound treatment method and device using standing waves | |
| US20140378887A1 (en) | Skin Treatment Device | |
| US20070219481A1 (en) | Apparatus and methods for the treatment of avian influenza with ultrasound | |
| US20090024076A1 (en) | Nozzle for ultrasound wound treatment | |
| EP1322275B1 (en) | Ultrasonic method and device for wound treatment | |
| WO1997017933A1 (en) | Method of spraying a surface using ultrasonic radiation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |